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I. INTRODUCTION 
The role of hormones has been investigated extensively with respect 
to their effects on mammary gland proliferation and milk production. In 
spite of continuous, intensive research there appears to be little pub­
lished concerning the effects of hormonal treatments on the biochemical 
mechanisms of the mammary gland. Likewise, what hormones are necessary 
and their optimal synergetic levels for maximal mammary gland growth are 
not fully known. 
This lack of biochemical and endocrinological information is due, 
in part, to the failure to use acceptable quantitative methods for 
estimating the degree of mammary gland proliferation. 
Much of our present knowledge relating to mammary gland growth has 
been obtained from qualitative assay methods. While such methods are 
reasonably accurate for estimating relative growth, they do not in all 
cases lend themselves as a definite means for studying the biochemistry 
of the gland. For studying the biochemica1-endocrinologica1 interrelations 
of the gland during growth, lactogenesis and involution quantitative 
procedures are imperative. Thus, we seek accurate quantitative measure­
ment procedures for studying the mammary gland. 
To begin looking for a quantitative criterion, we may ask ourselves 
one question: what measurable substance or substances, either directly 
or indirectly are influenced by hormones, will offer an accurate indication 
of the stage of proliferation, lactation or involution? To this, we can 
answer desoxyribonucleic acid (DNA), ribonucleic acid (RNAL), oxidized 
diphosphopyridine nucleotide (DPN) and reduced triphosphopyridine 
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nucleotide (TPN), because of their physiological importance in cell 
function. 
The DNA content of the individual cellular nucleus has been shown 
to be constant for somatic cells of a given species. As suggested by 
Davidson and Leslie (39) and Vendrely (189), the DNA constancy per cell 
can be used to determine the number of cells within a given tissue and 
can serve as a reference standard by which growth of a tissue may be 
expressed. Therefore, by using DNA as an index of mammary gland prolifera­
tion, one is able to obtain a quantitative measure of changes in the total 
number of cells of the mammary gland during various physiological and 
endocrinological periods. 
Recent investigations (197,204) have shown that RNA is essential 
for the direct control in the synthesis of cellular proteins. Thus, it 
seems reasonable to assume that a measurement of RNA in the mammary gland 
would represent an index of functional and structural protein biosynthesis, 
in both the tubular and alveolar cells, and of milk protein productivity 
in the alveolar cell. 
The presence of DPN or, more important, the value of the DPNH/DPN 
ratio as indicated by Clock and McLean (67,68) and McLean (119) is 
directly indicative of cellular oxidation, i.e., 
+2H+ 
DPN DPNH + H + 2e" (1) 
These authors further suggested that the ratio value could be equated as 
a measuring device of cellular oxidative phosphorylation. The function 
of oxidative phosphorylation is believed to be concerned with supplying 
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adenosine triphosphate (ATP) to the cell as a source of energy. Thus, 
measurement of DPN and DPNH would give information relating to the energy 
requirements of the mammary gland during stages of physiological develop­
ment . 
The measurement of TPNH (or the TPNH/TPN ratio) as suggested by 
Clock and McLean (67, 68) offers an accurate estimate of biochemical cell 
reduction, i.e., 
2e + TPNH + H TPN (2) 
This reduction has been suggested as being directly involved in fatty 
acid biosynthesis, because the rate of lipogenesis is limited by the 
availability of TPNH (176,200). Thus, measurement of TPNH would offer 
insight into the formation of adipose tissue and milk fat formation 
prior to, and during, lactopoiesis. 
The objectives of this dissertation are to measure the variability 
of DNA, RM, DPN, DPNH, TPN, and TPNH in the mammary gland of the rat 
by using quantitative procedures, and to investigate biochemical and 
endocrinological mechanisms of this gland. By measuring the variability 
of the above mentioned substances in the normal rat during pregnancy and 
lactation, and in the surgically ablated-hormonally treated rat, we may 
then gain insight into the effects of hormones on the gland and estimate 
the optimal levels of various exogenous hormones upon growth and normal 
function of the gland. 
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II. LITERATURE REVIEW 
The "humoral" concept for growth, development and function of the 
mammary gland was formulated by the early investigations of Grigoriew 
(78) and Knauer (96). These investigators observed normal mammary gland 
development in immature female laboratory animals following ovarian 
transplantation from mature females. This concept envisages that internal 
secretions, now known as hormones, directly affected the development of 
the gland. The later investigations of Steinach (168), Athias (11), 
Bresslau (20), Moore (137), Turner and Schultze (187), and Gardner (60), 
usinR grafted ovarian tissue in male and female animals, confirmed the 
"humoral" concept. Subsequent work by Laqueur e^ al.. (98), Turner and 
Schultze (187), Halpern and D'Armour (80)--using estrogens; by Turner 
and Frank (186), Mixner and Turner (130,131)--using progesterone; by 
Nelson (146), Astwood e^ £l. (10)--using estrogen and progesterone; by 
Van Heuverswyn (188), Leonard and Reece (99)--using corticosteroids and 
estrogens; by Weichert and Boyd (198,199)--using desiccated thyroid tissue, 
and by many others led to the belief that all hormones are involved, 
either directly or indirectly, in the development of the mammary gland. 
Those that directly affect mammary development coordinate physiological 
changes in the gland with changes in the reproductive system. This group 
of secretions consists of hormones from the ovaries, placenta, anterior 
pituitary and possibly the adrenal cortex. A second group of hormones 
would consist of those that are involved indirectly (or synergetically). 
These affect the metabolism and/or physiology of the mammary gland in 
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that they influence the general metabolism of the body. In this second 
group we usually consider insulin, thyroxine and the glucocorticoids, 
but other hormones are suspected and are being investigated for possible 
synergetic effects. A brief summary of the physiological changes in the 
mammary gland induced by each specific hormones is given below. These 
summaries shall be restricted to those hormones presently under investiga­
tion for the mammary glands of the rat and mouse. However, before 
considering the effect of varying hormones on mammary gland physiology, 
it is necessary to discuss normal development of the gland during periods 
in the life of the female rat. 
A. Normal Mammary Gland Development 
Mammary gland development and proliferation may be considered as 
consisting of three major periods: 
(1) embryonic, 
(2) pre-puberty, 
(3) puberty. 
1. Embryonic development 
The first trace of the mammary glands appears on the 11th day of 
embryonic life (83). The mammary streak arises from a single cell layer 
of the ventral ectoderm on either side of the midline and extends from 
the axilla to the inguinal region forming an obvious line which is 
elevated above the surrounding tissue. Further proliferation results 
in the localized concentration of epithelial cells along the mammary 
line which forms the mammary hillocks or buds. The mammary line connect­
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ing the buds gradually disappears leaving the isolated cellular masses. 
The number of buds corresponds to the number of mammary glands which will 
be formed in the adult animal. The mammary buds gradually sink into 
the underlying mesenchyme and becomes surrounded by the basement membrane. 
The primary sprout begins to develop about the 18th day of fetal 
life. The Malpighian layer forms a funnel shape outline and extends 
into the corium. One primary sprout develops from the proximal end of 
each bud, undergoes extensive branching and extends into the surround 
stroma. These extensions are the future interlobar ducts. No lobules are 
formed up to the time of birth (123,124,125). 
2. Pre-pubertal development 
At birth, the primary duct consists of a solid tube of cells. The 
secondary and tertiary ducts are all three-to-four cell layers thick. 
The tertiary ducts have one-to-three terminal branches (121). 
By the 10th day after birth, the epithelium of all ducts is two 
cell layers thick; the inner layer is composed of cuboidal cells, while 
the outer layer is irregular in size and shape. At two weeks of age 
the lumen of the primary and secondary sprouts are open and continuous 
with each other (122). 
From the 5th to the 10th week the mammary ducts slowly increase in 
size; the ducts are increased in length with many new ducts formed (122). 
End-buds are present on a large number of terminal ducts. This develop­
ment is greatly accelerated in the period immediately before puberty at 
approximately 10 weeks (158). No true alveoli are observed from birth 
to puberty (121,122,184,187). 
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3. Puberta1 development 
The sexunlly mature animal may have one of four possible conditions 
during its reproductive period: 
a. recurring estrous cycles, 
b. pregnancy, 
c, lactation, and 
d, involution. 
a. Recurring estrous eye les Mammary gland development has been 
observed to be closely related to the stage of the estrous cycle in the 
female rat (24,173). During proestrus the ductal system is composed of 
small, slender ducts which may or may not contain small mammary buds. 
At estrous, the buds may proliferate to varying degrees; additional ones 
may also appear. By the time corpora lutea have formed, an increase in 
the complexity of the secondary ducts may be seen (173). This additional 
development may not be completely lost by the next proestrus period, 
therefore, during the next estrous cycle the mammary glands may progress 
to a more advanced stage of development. 
b. Pregnancy During pregnancy the mammary gland is characterized 
by the formation of lobules and alveoli and an increase in the glandular 
tissue. Lobule formation is evident after 10 days of pregnancy in the 
rat. The alveoli are spherical and gradually increase in size until the 
time of parturition. Cell division was thought to cease by the 13th day 
of pregnancy and the number of cells around the alveoli were believed to 
be maximum at this time. Further increase in size of the mammary gland 
was thought to occur from increase in size of both the capillaries and 
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alveoli of the mammary gland. Vacuolization of the alveoli, which is 
indicative of secretory activity, is found about the 13th day of 
pregnancy and reaches a maximum by the 19th day of pregnancy (161). 
Jeffers (89) observed that the lumina of the alveoli increase in 
size during the last half of pregnancy; the average diameter at 13 days 
was 30.8 microns and by the 20th day had increased to approximately 40.6 
microns. In contrast to Roberts (161), Jeffers (89) also reported an 
increase in the number of cells lining a single alveolus. Alveoli from 
the 12th to 18th day of pregnancy contained an average of 8.09 cells per 
alveolus, from the 19th-20th day of pregnancy the average number had 
increased to 10.1 per alveolus. 
The colchciine technique was employed by Reece and Warbritton (157) 
to estimate mitotic rate of the mammary gland during pregnancy. The 
percentage of cells undergoing division on the 5th day of pregnancy was 
4.6, on the 10th day 17.3, on the 15th day 9.3, and on the 20th day 1.1 
percent. 
c. Lactation Macroscopic aspects of the mammary gland during 
lactation remains the same as at the end of pregnancy. The glandular 
parenchyma consists of closely packed lobules and the ducts and alveoli 
are extended with secretion. The alveolar cells vary in shape due to 
either the distension of cells by the accumulation of milk or collapse 
of the cells which follow milk removal. When the cells are empty, the 
alveolar epithelium is folded and the cells are so elongated that apical 
cytoplasm projects into the empty lumen. After removal of milk from the 
alveoli, secretory material again accumulates, and as more is secreted 
the cells become stretched and thin (159). 
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Jeffers (89) reported the mammary gland resembles that character­
istic of lactation 12 to 15 hours after parturition, and lactation is 
established 24 hours after parturition. 
d. Involution Forty-eight hours after weaning, the mammary 
glands have the same general appearance as during lactation. The alveoli 
are widely distended with secretion and secretory activity is still 
obvious. By the 3rd day the parenchyma is reduced in proportion to 
stroma, and the glandular substance occurs in groups of small masses. 
The alveoli which are distended with secretion are greatly reduced, 
although some secretory activity is still evident. Only a small number 
of alveoli are present by the 5th day. The majority of the glandular 
tissue has been replaced by increased amounts of adipose tissue. By 
the 9th day after weaning, the mammary glands again resemble those of a 
normal adult virgin animal (115). 
B. The Effect of Hormones and Related Substances 
on Mammary Gland Proliferation 
1. Estrogen 
Earliest investigations of the "estrogenic" effect on the mammary 
gland were those of Laquer and associates (98), Turner and Schultze 
(187), and Halpern and D'Armour (80). These studies suggested that 
estrogen directly affected the gland by causing ductal growth without 
alveolar formation. Later studies by Astwood ejt a_l. (10), using estrone, 
by Lewis and Turner (101), using diethylstibestriol, and by Reece and 
Bivins (156), Nandi (143), and MacDonald and Reece (113), using estradiol, 
confirmed the investigations of the earlier workers and, in essence. 
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equated the effect of estrogenic compounds with ductal growth in the 
mammary gland. Detailed summaries and reviews of the actions of estro­
genic substances are given by Folley and Malpress (57), Mayer and Klein 
(117), Folley (55), Diczfalusy and Troen (42), and Jacobsohn (88). 
2. Progesterone 
Progesterone, as a single hormone, has been shown in ovarectomized 
animals by Turner and Frank (185,185), Astwood and associates (9,10) 
and Mixner and Turner (128,130) to be incapable of stimulating, except 
in abnormally large amounts, mammary proliferation. 
3. Estrogen and progesterone 
The observation that a combination of estrogen and progesterone is 
necessary to induce additional mammary growth was made by Nelson (145). 
This work was confirmed by Lyons and McGinty (111), Reece and Bivins 
(156), Turner and associates (35,36,51,52,94,95,192), Reece (113). 
Elliott and Turner (51,52) using the spreading factor technique found 
that a particular ratio of estrogen to progesterone was necessary to obtain 
lobular-aIveolar development comparable to normal late pregnancy. These 
workers suggested 1 ug of estradiol to 5 mg progesterone or a ratio of 
1:5000, Damm and Turner (35) suggested that once the particular ratio 
was established, additional progesterone, with due regard to the ratio, 
could be added to approximate more closely the normal pregnant condition. 
Similar results have been obtained by Cortiss (30), Lyons e_t a_l. (109), 
Nandi (143), Moon e^ (135) and Munford (140). From these and other 
studies, the optimal ratio of estrogen and progesterone necessary to 
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simulate mammary development in the rat equivalent to that at the end of 
a normal pregnancy was considered to be 1:2000 (135). The ratio has been 
now established as 1:3000 by Ahrén and Jacobsohn (3), Anderson and 
Turner (6), Damm and Turner (38) and Griffith and Turner (74,75) along 
with other investigators. 
The combined effect of estrogen and progesterone has been shown by 
Damm e_t a_l. (35) to be exclusively related to progesterone. These 
investigators studied the progesterogenic effect of various derived 
metabolites, i.e., pregnenolone, 17 a hydroxyprogesterone, andostenedione 
and testosterone, in combination with estrogen. Considering the estrogen-
pregesterone effect as unity, the results were 0.29, 0.26, 0.36, and 0.33 
percent, respectively, for the metabolites listed above. 
4. Adrena 1 cortica 1 homes and steroids 
The involvement of adrenal cortical hormones and steroids in mammary 
gland proliferation was first suggested by Van Heuverswyn, £t a_l. (188) 
working with desoxycorticosterone acetate (DCA). Since that time much 
research has been generated to study the effects on the mammary gland of 
individual cortical hormones, alone and in combination with other non-
cortical hormones. Investigations by Gaunt (64,65), Leonard and Reece 
(99), Smith and Braverman (163), Johnson and associates (90,91), Rivera 
and Bern (160), and Nandi (143)--using DCA ; Jacobsohn (86,87), Lyons 
et al. (108), Johnson and Meites (91), and Ahren and Jacobsohn (4,5)--
using adrenal corticaItropic hormone (ACTH) ; Talwalker £t a_l. (175), 
Griffith and Turner (75), and Anderson and Turner (6,7)--using hydro­
cortisone (HCA); Nelson e_t aj^. (148), Anderson and Turner (7,8)--using 
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DCA. and HCA ; and Cowie and Tindal (31)--using aldosterone have shown 
that adrenal cortical hormones act synergistically with estrogenic 
compounds and progesterone, in the ablated animal, to aid in mammary 
gland proliferation, but are primarily responsible for proper mammary 
development and function during the lobular and lactational phases of 
the gland (109). 
Smith and Braverman (163) conducted extensive research ou the action 
of DCA alone and in combination with estradiol and progesterone on the 
development of the mammary gland of ovarectomized rats. The authors 
concluded that DCA alone influences ductal proliferation and in combina­
tion with progesterone, it does not affect lobule-alveolar growth. Wlien 
given with estradiol, DCA is less active than the proliferation induced 
by estrogen and progesterone. 
Anderson and Turner (6) obtained mammary growth in adrenalectomized--
ovarectomized animals, as measured by DNA, upon giving E, P, and HCA. 
The measured growth, however, was less than that obtained from giving E 
and P with HCA. Giving E, P, and DCA, DCA and HCA alone resulted in no 
proliferation above the ovarectomized control. These same authors (7,8) 
obtained proliferation in ovarectomized animals upon giving E, P, and 
HCA. 
5. Thyroxine 
The effect of thyroxime upon mammary gland proliferation and function 
is not completely known. The early studies by Dragstedt ^  aj^. (47), 
Weichert and Boyd (198,199), Nelson and Hickman (149), Leonard and Reece 
(100), Smithcors and Leonard (165), Mixner and Turner (129), and 
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Smithcors (164) gave confusing and conflicting results. These were 
believed due to differences in the source and the purity of hormonal 
preparations (109). More recent and extensive investigations by Blaxter 
(16), Chen et a_l. (23), Lyons e_t £l. (109), Moon and Turner (136), Moon 
(133), and Randle (153)--to mention only a few--have suggested that 
thyroxine may be a limiting factor in mammary gland growth when estrogens 
and progesterone secretions are adequate. Moon (133) indicates that 
thyroxine influences production and secretion of prolactin. 
6. Anterior pituitary hormones 
The relationship of hormones from the anterior pituitary in mammary 
gland proliferation was first investigated by Strieker and Grueter (172). 
These investigators observed that hypophysectomy in the adult female 
resulted in the cessation of mammary function and growth. This observa­
tion was confirmed by the later work of Corner (29), Selye e_t a_l. (162), 
Nelson (146), Nathanson e^ aj^. (144), Gardner (61,62), Gardner and 
White (63), Hooker and Williams (84) and Lyons (104). The work of the 
above mentioned investigators made it apparent that after hypophysectomy 
no exogenous injection (excluding an anterior pituitary extract) would 
produce normal mammary proliferations. This conclusion, along with more 
advanced purification methods, stimulated further investigations by 
Lyons ^  a_l. (112), Nelson £t aJL. (145), Williams (201), Trentin and 
Turner (177), Lyons (104,105,106), Desclin (41), Lyons and associates 
(34,108,109,112), Jacobsohn (85), Cowie and associates (14,18,19,32,33), 
Randle (154), Flux (55), Nandi (143), Linzell (103), Bern (15), Damm 
and Turner (37,38), Talwalker and Meites (174), Moon (132), Chandra and 
Cole (22), Cole and Hopkins (25,26), Ota et £l. (151), Danamur (40), 
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Griffith and Turner (75), MacDonald and Reece (113), Anderson and Turner 
(8) and Djojosoebagio and Turner (46) in an attempt to determine the 
specific hormone from the anterior pituitary and the proper synegrists 
important in mammary gland proliferation. As a result of the above 
investigations--except for Trentin and Turner (177)--the specific hormone 
is generally accepted to be prolactin (mammotropin) and is believed to 
act synergistically with ovarian hormones to produce normal mammary gland 
growth. The work of Trentin and Turner (177) suggests a specific mammary-
developing hormone, mammogen, which is believed to act directly on the 
gland due to stimulation of the anterior pituitary by the ovarian 
hormones. However, thorough chemical examinations as reported by Hays 
and Steelman (82), Li and Evans (102), Lyons (109), Ray e_t al^. (155), 
and Gala and Reece (59) have failed to yield such a hormone. 
A second hormone of importance in mammary gland proliferation is 
somatotropin (growth hormone). This hormone is believed to stimulate 
proliferation by increased ductal branching in the gland (108,109,112, 
143). The recent work of Knobil and Hotchkiss (97) suggest that 
somatotropin may further messenger--RNA production. These authors 
concluded this from experimentation with hypophysectomized animals with 
and without hormonal therapy. However, Cowie and Tindal (32), with 
animals hypophysectomized on the 12th day of pregnancy and injected with 
prolactin and ACTH from the 20th day of pregnancy through the 10th day 
of lactation obtained 53 percent normal milk production. Thus, it 
appears that somatotropin acts only as synergist with prolactin for 
better enhancement of the effect which prolactin has on the mammary 
gland (22,26). 
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C, The Effect of Hormones and Steroids on the 
Concentrations of DNA., RM, DPN, DPNH, TPN, and 
TPNH in the Mammary Gland During Proliferation 
The effects of exogenous hormonal injections upon the concentrations 
of DNA, RNA, DPN, DPNH, TPN, and TPNH are not completely known. Our 
present knowledge is limited because of the wide range of needed experi­
mentation, and the direction of the present experimentation being done. 
Because of the wide distribution of possible investigations, and con­
centrated efforts in one area--measurement of DNA concentration--this 
section will include brief discussion of the suggested physiological 
function of each of the involved substances in the mammary gland and a 
short review of investigators working in this area. 
1. DNA 
The work of Boivin ^  (17) suggested that, for a given species, 
the DNA concentration per somatic cell was constant. This work was 
extended and confirmed by Mirsky and Ris (126,127) and Davidson (39). 
Davidson (39) suggested that the constant DNA concentration could be 
used to determine the total number of cells in a given tissue. Turner 
and associates (6,7,8,21,35,36,37,38,46,73,74,75,76,77,94,95,135,136, 
192), Greenbaum and associates (71,72), Wang and Greenbaum (193,194), 
Moon (134), Cole and associates (22,25,26), Tucker and Reece (178,179, 
180,181,182,183), and many others have used this criterion as a quanti­
tative measure of mammary gland growth in normal and ablated rats with 
and without exogenous hormonal injections. These studies empirically 
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correlate growth changes with those observed and measured qualitatively 
by histological investigations. However, while most investigators use 
this method to measure proliferation, Munford (139,140,141) feels 
histological procedures are the more accurate and should continue to be 
used. 
2. RNA 
That the RNA concentration in the mammary gland was an estimate of 
protein synthesis in the gland was first suggested by Sternberg (171) 
and Kirkham and Turner (95). The reports of Zamecnik (204), Wang £t al. 
(195), and Watson (197) seemingly confirm the suggested view. 
The use of this measurement for studying the gland has been limited. 
Only until recently with the work of Greenbaum and associates (71,72) 
Bailie and Morton (12,13), Wang and Greenbaum (193,194), Chandra and 
Cole (22), Talwalker and Meites (174), Cole and Hopkins (25,26) Ota 
et al. (151), Tucker and Reece (178,179,180,181,182,183) and MacDonald 
and Reece (113,114), have we gained some understanding of changes in the 
protein synthesis capabilities of the gland during normal physiological 
periods of the animal. The investigations of Cowie and Tindal (32) 
and Knobil and Hotchkiss (97) offer insight in changes of proteidogenetic 
abilities in the hypophysectomized animal with hormonal therapy, 
3. DPN ^  DPNH 
Clock and McLean (66,67,68) the first to study these substances 
in the mammary gland, sought information relating to the energy require­
ments of the gland during lactation. Further investigations by Abraham 
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et al. (1,2), Stern and Vennestand (169,170), Nakamoto and Vennestand 
(142), Jones and Gutfreund (92), and Mason (116) have primarily been 
concerned with the biochemistry of these nucleotides in the normal 
animal. Pastan et_ £]^. (152), however, investigating the reduced form 
of this nucleotide iji vitro with thyroxine therapy observed no change in 
the concentration of this substance. 
4. TPN and TPNH 
The work of Clock and McLean (67) initially led the way for further 
investigations in an attempt to understand the biochemical mechanics of 
cellular reduction during lactation. This reduction has been indicated 
by Tepperman and Tepperman (176), Dumont (48,49), Abraham ^1. (1,2), 
Pastan ejt a_l. (152), Mason (116), Oils and Popjak (44), Oils and Clark 
(43) and Coniglio and Popjak (28) to be directly involved with fatty 
acid biosynthesis in the gland. The reduced form of this nucleotide 
was found to slightly increase upon the addition of exogenous thyroxine 
(152) and to increase during lactation (58). 
Harding and Nelson (81) and Eik-Nes (50), studying the adrenals 
in hypophysectomized rats observed no change in the TPNH/TPN ratio. 
Eik-Nes (50) concluded that there may exist other routes for TPNH 
production other than the pentose pathway. Other possible sources for 
the formation of TPNH are: transhydrogenation of TPN, utilizing the 
hydrogen of either DPNH (93,167,169,170,190) or estradiol (79), and 
transphosphorylation of DPN (196). Transphosphorylation was observed 
in the thyroid following the injection of thyrotropin (53,54,152). 
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Likewise, thyrotropin stimulates the oxidation of glucose via the pentose 
pathway in the thyroid (138). Thus all systems are suggested to be 
involved in TPNH production. 
19 
III. METHODS 
A. Animals 
Normal and surgically ablated primiparous Sprague-Dawley-Rolfsmeyer 
rats, all initially weighing between 205 and 220 gins., were used in this 
investigation. All animals were fed and watered a_d libitum, were cleaned 
biweekly, and were housed in cages containing only members of the same 
operative-treatment group combination. 
Ovarectomized (0 ) and/or adrenalectomized (A ) animals were 
bilaterally ablated via two incisions at one operation. This was done 
to minimize the amount of cicatrical tissue, to reduce trauma brought 
about by anesthesia, and to reduce the mortality rate of the animals. 
All surgery on hormonally treated animals was performed 7 to 10 days 
prior to the beginning of the experimental period. Surgery on animals 
receiving no hormonal treatment was completed 27 to 30 days prior to 
their sacrifice. Nembutal was used as an anesthetic. Both A and A -0 
A A X 
animals received special fluid, containing 0.5 percent NaCl and 0.5 
percent glucose, from recovery until sacrificed, regardless of hormonal 
therapy. 
Hypophysectomized (H^) Sprague-Dawley-Rolfsmeyer rats were purchased 
from Hormone Assay Laboratories; these animals upon their arrival were 
0 and/or A as necessary and in accordance with the above mentioned 
experimental time and surgical restrictions. All hypophysectomized 
animals, i.e., H^, A^ - H^, H^ - 0^, and maintained 
on special fluid. For simplicity we shall denote A - H - 0 by T 
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henceforth. 
Normal and surgical ablated animals receiving hormonal therapy 
were given prescribed daily hormonal injections, subcutaneously, in the 
middle dorsal region at the base of the neck, after the recovery period 
of from 7 to 10 days. These injections were continued during the experi­
mental period of 19 days to induce lobule-alveolar development. On 
experimental day 20, the animals were sacrificed. The daily exogenous 
doses of the hormones used are as shown in Table 1. Table 1 also gives 
the symbolic notation used henceforth in the text, along with the specific 
carrying media or the mode of injection used with each of the various 
hormones. 
Upon sacrifice of the animals all abdomino-inguinal mammary glands 
were removed, separately for each animal, and frozen for DNA and RM 
determinations, as described below. Two small portions of the pectoral 
mammary glands, ranging from 56 mgms to 250 ragms were removed and homo­
genized separately for the determinations of oxidized and reduced 
coenzymes, i.e., DPN, TPN, DPNH, and TPNH. In addition, a third portion 
of pectoral gland was removed for histological purposes. 
B. Determinations 
In all cases the analytical methods for the determinations were 
those used by earlier workers in mammary tissue assays. The method of 
Ogur and Rosen (150) was used to determine DNA and RNA. concentrations. 
The oxidized and reduced forms of the coenzymes were prepared and 
determined--with the exception of TPNH--by the method of Clock and 
McLean (66), as modified by Villee (191). Isocitric dehydrogenase, in 
Table 1. Injected exogenous hormonal compounds used during experimental period 
Hormona1 
compound 
Symbolic 
notation 
Exogenous dose 
(per animal per day) 
Carrier media or 
mode of injection 
Estrone E 2 jugms Corn oil 
Progesterone P 6 mgs Corn oil 
Thyroxine T 3 y/100 gras Body weight Sa line 
Desoxy-
corticosterone 
DCA 0.25 mgms Distilled water-
crystalline suspension 
Hydrocortisone 
acetate 
HCA 500 /igras Distilled water-
crystalline suspension 
Growth hormone STH 1 mgm Sa line 
Prolactin 
(mammogen) 
M 1 mgm Sa line 
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the presence of isocitric acid and the neutralized acid tissue extract, 
was used to determine DPN, instead of glucose-7-phosphate dehydrogenase 
as prescribed (27). All samples were analyzed spectrophotometrically, 
by use of the Spectronic 505 (U.V,), or colorimetrically, by use of the 
Spectronic 20 (visable). 
In order to determine specific concentrations of coenzymes, the 
method of differences was employed. That is, since isocitric dehydro­
genase reduces both DPN and TPN and alcohol dehydrogenase specifically 
reduces DPN, the total concentration of TPN, in per 100 mg of mammary 
tissue, was calculated by subtracting the total DPN, in as determined 
by alcohol dehydrogenase, from the combined total of DPN and TPN, in ijM.. 
Likewise, since diaphorase (from Clostridium kluyveri) oxidizes both 
DPNH and TPNH, and diaphorase (from pig heart) oxidizes only DPNH, the 
total concentration of TPNH, in ^ M, was calculated from combined total, 
i.e., DPNH and TPNH, in pN minus the total DPNH, in pH. 
All drugs were obtained from the Sigma Chemical Co. (Sigma), 
except two hormones--growth hormone and prolactin, which were a gift 
from the National Institutes of Health. Diaphorase (Clostridium 
kluyveri) which was obtained from General BiochemicaIs. 
Histological preparations were prepared by fixing, staining and 
cleaning pectoral gland tissue in accordance with the method of Lyons 
and Johnson (107). Once cleared, they were embedded in paraffin, and 
sectioned at 50 p., permanent slides were made. 
Complete descriptions of the analytical and histological methods 
used in this experimentation are given in the Appendix. 
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IV. RESULTS 
The results obtained from the present experimentation are given 
below. To simplify this presentation, these results will be separated 
into two groups, in accordance to type of mammogenesis--natura1 and 
artificial. 
A. Natural Mammogenesis 
The individual group mean value and the associated standard error 
of that mean for each of the measured substances for pregnancy and 
lactation are given, along with pertinent ratios, in Chart 1. In this 
table, and henceforth, the following notations will be used for 
simplicity in discussing measurement periods during pregnancy and lacta­
tion. 
= normal pregnant animal at the i^^ day of gestation. 
= normal lactating animal at the i^^ day of nursing. 
i 
In addition, photographs of the anatomical glandular changes occurring 
in the gland for the 5th, 10th, 15th, and 20th day of pregnancy, and the 
1st, 5th, 10th, 15th, and 20th day of lactation are illustrated in 
N 
Figures 1 through 9. The glands of the normal control ( P^) are shown 
in Figure 10. 
B. Artificial Mammogenesis 
The results for artificial mammogenesis will be presented in 
regards to operative-treatment group combinations. However, before 
chart 1. Means and standard errors of means for pregnancy and lactation 
Time of 
measure 
2 0  
15 
10 
ho 
"15 
10 
'^ 0 
Noteï 
(1) 
(1)  (2)  (2)  (3)  (3)  (3)  (3)  
io. exptl . Pertinent Final TRXA/lOO Ratio TPN/100 TPNH/100 Ra t io DP;:/100 DPNH/100 Ratio 
anima Is statistic anir.a 1 T 
RNA 
mgm. M.T. mgm. M.T. TPNH mgm.M.T. mgm. M.T. DP;: 
weight gras. B.W. g^is. B.W. (wM) TPN (J-l) (UM) DPNH 
(gms.) (mgm.) (mgm.) 
9 X 276.9® 6.16 7.90 0.78 405.1 678.2 1.67 269.1 7.3 36.86 
8- ^0.46 +0.38 +15.69 +22.98 +16.89 +0.76 
7 X 266.0® 3.38 6.62 0.51 24.6 298.4 12.13 496.9 8.3 59.87 
8- 0.23 0.25 3.37 10.91 12.12 0.26 
8 X 262.2® 1.86 4.32 0.43 80.6 851.1 10.56 387.4 4.5 86.09 
8- 0.27 0.31 8.05 36.69 9.11 0.35 
6 X 228.7 1.68 3.42 0.49 277 .1 559.7 2.02 51.1 6.1 8.38 
"x 
0.16 0.20 17.99 26.73 5.01 0.83 
6 X 227.2^ 31.17 11.07 2.81 135.9 1700.1 12.51 154.1 16.8 9.17 
3- 0.62 0.23 8.63 33.08 11.13 0.30 
7 X 262.9 26.80 10.43 2.57 247.4 5851.0 23.65 292.0 12.8 22.81 
3- 0.91 0.19 13.92 102.17 19.03 1.75 
6 9. 255.1 23.67 10.59 2.24 104.8 2002.7 19.11 397.4 4.2 92.24 
0.47 0.21 14.37 74.57 24.48 0.27 
8 X 256.4 16.23 10.47 1.54 76.4 1146.0 15.00 359.2 11.1 32.36 
0.36 0.27 6.07 41.36 22.51 0.96 
6 X 248.4 10.28 8.49 1.21 43.6 557.6 12.79 285.7 2.9 98.52 
"x 
0.29 0.31 3.98 16.45 21.17 0.09 
12 X 226.9 1.12 3.20 0.35 525.8 373.3 0.71 0.0 24.6 0.0 
s-
X 
0.21 0.29 16.09 14.18 0.0 4.26 
in this chart and Charts 2, 3,  4,  5,  I ind 6 :  
X = Sum of individual observations for a given measurement period divided by the total number of observations for 
that period, i.e., 
X = E X /n, and 
1=1 
 ^ 2(x^ -x)^  
"x = ^  n(n-l) 
1/2 
= — , where 3 is the estimated standard error of the population for a given measurement period. 
Vn 
(2) Tj^/100 gms. B.H. is total RNA (or DNA) per 100 gias. body weight of animal, in mgms. 
(3) TPN/100 mgm. M.T. ia total TPN (TPNH, DPN or DPNH) per 100 mgms. of wet weight of matnmary gland tissue, in uM. 
M 
-P> 
Final animal weight adjusted for fetal weight. 
Mother was still nursing young. 
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Figure 1. Mammary gland from a normal pregnant (N^ ) rat 
26 
Figure 2. Mammary gland from a normal pregnant (N ) rat 
10 
27 
Figure 3. Mammary gland from a normal pregnant (N ) rat 
^15 
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Figure 4. Mammary gland from a normal pregnant (N ) rat 
20 
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Figure 5. Mammary gland from a normal lactating (N^ ) rat 
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Figure 6. Mammary gland from a normal lactating (N^ ) rat 
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Figure 7. Mammary gland from a N 
Mammary gland from a N, 
33 
Figure 9. Mammary gland from a N rat 
2^0 
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Figure 10. Mammary gland from a normal virgin (N ) rat 
0 
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presenting the results, it is necessary to explain symbolism used 
henceforth. All operative-treatment combinations shall be denoted in 
accordance with the following symbolism for simplicity: 
Operative groups: 
0^ = normal control (N^) animal, 
0„ = ovarectomized (0 ) animal, 
0_ = adrenalectomized-ovarectomized (A - 0 ) animal, 
J A X 
0^ = hypophysectomized-ovarectomized (H^ - 0^) animal, 
0^ = hypophysectomized animal, 
0, = adrenalectomized-hypophysectomized (A - H ) animal, 
D A X 
0^ = adrenalectomized, hypophysectomized and ovarectomized (T ) / X 
anima 1. 
Treatment groups: 
= no treatment (N.T.) 
= hormonally treated with E and P, 
- hormonally treated with E, P and T, 
= hormonally treated with E, P, DCA and HCA, 
= hormonally treated with E, P, DCA, HCA and T, 
Tg = hormonally treated with E, P, STH, M and T, 
Ty = hormonally treated with E, P, STH and M, 
Tg = hormonally treated with E, P, DCA, HCA, STH, and T, 
Tg = hormonally treated with E, P, DCA, HCA, M and T, 
T^Q= hormonally treated with E, P, DCA, HCA, STH, M and T. 
The above symbolic notations are derived from utilizing an incomplete 
block statistical arrangement. The symbolic notations used to denote 
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hormonal treatments are explained above in Table 1. 
1. Normal animals (0^) 
This experimental group was set up to determine the effects of 
treatment, on the intact animal with a complete system of controlling 
mechanisms, feed-back and synergistic interrelations. The results for 
this group are given in Chart 2 . 
a. T^ This subgroup of normal, intact animals receiving no 
N 
treatment was mentioned above, as , and will not be considered. 
b. T^ This subgroup received E and P at the concentrations 
indicated in Table 1. The means obtained as shown in Chart 2 were 
3.87, 6.00, 317.1 301.2, 215.2, and 3.1 for RNA, DNA, TPN, TPNH, DPN, 
and DPNH, respectively. The pertinent ratio values for RM/DNA, 
TPNH/TPN are DPN/DPNH were 0.64, 0.95, and 69.42, respectively. The 
extent of proliferation is shown in Figure 11. 
c. T^ This subgroup received E, P, and T. The extent of 
proliferation is shown in Figure 12. The means of the six involved 
substances and the ratio values were 8.71, 7.88, 1.10, 328.1, 275.6, 
0.84, 290.2, 3.4, and 85.35, for RNA, DNA, RNA/DNA, TPN, TPNH, TPNH/TPN, 
DPN, DPNH, and DPNH/DPN, respectively. To avoid continuous reiteration 
of the order in which the substances and their ratios are listed, the 
above ordering shall be followed throughout this section, i.e., as 
shown in each data mean summarization table. 
d. T^ The means of the measured substances and their ratio 
values, as shown in Chart 2, were 6.11, 5.75, 1.06, 209.5 282.8, 1.35, 
91.0, and 0.0. The ratio value of DPN/DPNH was indeterminated, since 
Chart 2. Means and standard errors of means for operative group number 1 
(1) (2) (2) (3) (3) (3) (3) 
Treat­ No. of Pertinent F ina 1 per TDNA Ratio TPN per 
TPNH per Ratio DPN per DPNH per Ratio 
ment expéri­ statistic anima 1 
''•RNA^DNA 
100 mgms. 100 mgms. TPNH/TPN 100 mgms. 100 mgms. DPN/DPKH 
group menta 1 weight 100 gms. 100 gms. M.T. M'.T . M.T. M.T. 
anima Is (gms.) B.W. B.W. 
(mgm) 
12 
- • 
X 226.9 1.12 3.20 0.35 525.8 373.3 0.71 0.0 24.6 0.0 
8-
X 
+0.21 +0.29 +16.09 + 14.18 0.0 +4.26 
Tg 8 X 226.0 3.87 6.00 0.64 317.1 301.2 0.95 215.2 3.1 69.42 
S- 0.36 0.38 13.47 11.29 9.50 0.14 
T3 8 X 234.7 8.71 7.88 1.10 328.1 275.6 0.84 290.2 3.4 85.35 
8- 0.41 0.24 24.98 17.78 12.79 0.06 
8 « 217.6 6.11 5.75 1.06 209.5 282.8' 1.35 91.0 0.0 CO 
8. 0.35 0.43 8.72 12.77 5.48 0.0 
T5 8 X 220.5 6.87 5.97 1.15 399.0 367.1 0.92 145.8 0.0 00 
8. 0.37 0.35 14.70 20.33 9.99 0.0 
Tg 8 X 260.8 9.30 6.66 1.40 215.6 247.9 1.15 307.5 3.7 83.11 
"x 
0.37 0.27 19.56 13.00 12.16 0.09 
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Figure 11. Mammary gland from a normal virgin (N^) rat hormonally 
treated with esteone (E) and progesterone (P) 
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Figure 12. Mammary gland from a rat hormonally treated with E, P 
and thyroxine (T) 
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the concentration of DPNH was zero; therefore it was called infinite 
(oo). This subtroup received as a hormonal treatment E, P, DCA, and HCA 
and is shown in Figure 13. 
e. This subgroup received E, P, DCA, HCA, and T, see Figure 
14. The respective values of the substances were 6.87, 5.97, 1.15, 
399.0, 367.1, 0.92, 145.8, 0.0, and œ. 
F. Tg This subgroup received E, P, STH, M, and T. The mean 
and ratio values were 9.30, 6.66, 1.40, 215.6, 247.9, 1.15, 307.5, 3.7, 
and 83.11. Histological results are shown in Figure 15. 
2. Ovarectomized animals (C^) 
The results for this operative group are given in Chart 3. 
a. T^ These ovarectomized animals, receiving no hormonal 
treatment had the following mean and ratio values: 1.20, 3.12, 0.38, 
432.0, 155.5, 0.36, 70.7, 8.4, and 8.42. See Figure 16. 
b. T^ This subgroup, shown histologically in Figure 17, 
received the hormonal injections E and P. The mean and ratio values for 
the measured substances were 4.78, 7.24, 0.66, 200.5, 192.5, 0.96, 15.6, 
1.5, and 10.40. 
c. T^ This subgroup, as shown in Figure 18, had measured mean 
and ratio values of 15.40, 9.40, 0.64, 231.8, 259.6, 1.12, 19.8, 9.4, 
and 2.11. 
d. T^ The mean and ratio values of this subgroup were 10.31, 
6.77, 1.52, 248.5, 226.1, 0.91, 0.0, 14.4, and 0.0. A histological 
section is shown in Figure 19. - -
Chart 3. Means and standard errors of means for operative group number 1 (Og) 
(1) (2) (2) (3) (3) (3) (3) 
Treat­ No. of Pertinent Final 
^RNA P" 
per _ 
100 gms. 
B.W. 
TPN per TPNH per Ra tio DPN per DPNH per Ratio 
ment experi- statistic anima 1 100 mgms. 100 mgms. TPNH/TPN 100 mgms. 100 mgms. DPN/DPNH 
group mentaI 
anima Is 
weight 
(gms.) 
100 gms. 
B.W. 
(mgm) 
M.T. M.T. M.T. M.T. 
6 X 256.6 1.20 3.12 0.38 432.0 155.5 0.36 70.7 8.4 8.42 
=X iO.33 +0.13 +19.23 +21.32 +3.69 + 1.15 
19 X 250.5 4.78 7.24 0.66 200.5 192.5 0.96 15.6 1.5 10.40 
0.37 0.46 17.49 16.39 2.14 0.02 
17 X 225.1 15.40 9.40 0.64 231.8 259.6 1.12 19.8 9.4 2.11 
=X 0.29 0.27 11.78 15.59 2.71 0.64 
19 X 228.9 10.31 6.77 1.52 248.5 226.1 0.91 0.0 14.4 0.0 
S- 0.23 0.38 14.07 24.98 0.0 1.01 
8 X 236.5 15.65 8.42 1.86 236.7 416.6 1.76 15.9 7.8 2.04 
=x 0.46 0.29 12.45 17.12 1.17 0.76 
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Figure 13. Mammary gland from a N rat horraonally treated with E, P, 
desoxycorticosterone (DCA) and hydrocorticosterone (HCA) 
43 
Figure 14. Mammary gland from a N rat hormonally treated with E 
DCA, HCA and T 
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Figure 15. Mammary gland from a rat hormonally treated with E, P, 
growth hormone (STH), prolactin (M) and T 
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Figure 16. Mammary gland from an ovarectomized (0^) rat receiving no 
hormonal treatment 
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Figure 17. Mammary gland from an 0 rat hormonally treated with E and P 
47 
Figure 18. Mammary gland from an 0 rat horraonally treated with E, P 
and T 
48 
Figure 19. Mammary gland from an 0 rat hormonally treated with E, 
D and H 
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e. This subgroup, receiving E, P, STH, and M, have mean 
and ratio values of 15.65, 8.42, 1.86, 236.7, 416.6, 1.76, 15.9, 7.8, 
and 2.04. See Figure 20. 
3. Adrenii lectomized-ovarectomized animals (0^) 
a. T^ This subgroup had mean and ratio values, as given in 
Chart 4, of 4.06, 3.95, 1.02, 176.8, 47.7, 0.27, 6.5, 0.0 and 
See Figure 21 for a histological section. 
b. The mean and ratio values of this subgroup were 4.61, 
7.33, 0.63, 192.8, 79.0, 0.41, 14.9, 6.7, and 2.22 for RNA, DNA, RiNA/DNA, 
TPN, TPNH, TPNll/TPN, DPN, DPNIi, and DPN/DPNH, respectively. The extent 
of proliferation is shown in Figure 22. 
c. This subgroup received E, P, DCA, and HCA, had mean and 
ratio values of 11.65, 7.17, 1.62, 310.7, 183.3, 0.59, 0.0, 1.33, and 
0,0. (See Figure 23). 
d. This subgroup, as shown in Figure 24, had mean and ratio 
values of 14.62-, 8.75, 1.63, 254.5, 193.4, 0.76, 21.6, 49.6, and 0.44 
To reiterate, this subgroup received as hormonal therapy E, P, DCA, 
HCA, and T. 
4. Hypophysectomized-ovarectomized animals (0^) 
The results for the operative group are to be found in Chart 5. 
a. T^ This experimental operative-treatment subgroup, receiving 
no hormonal treatment, had mean and ratio values of 1.65, 1.97, 0.84, 
761.7, 236.7, 0.31, 15.7, 0.0 and oo. (See Figure 25). 
Chart 4. Means and standard errors of means for operative group number 1 (0^) 
Treat­
ment 
group 
No. of 
expert -
menta 1 
animals 
(1) 
Pertinent 
statistic 
Fina 1 
anima 1 
weight 
(gms.) 
( 2 )  
100 gras. 
B.W. 
(mgm) 
( 2 )  
D^NA P" 
100 gms. 
B.W. 
Ratio 
'^ rna/^ DNA 
(3)  
TPN per 
100 mgtns. 
M.T. 
(3)  
TPNH per 
100 mgms. 
M.T. 
Ratio 
TPNH/TPN 
(3)  
DPN pgr 
100 mgms. 
M.T. 
(3)  
DPXH per 
100 mgms. 
M.T. 
Ratio 
DPN/DPNH Ln 
O 
6 S 206.5 4 .06 3.95 1.02 176.8 47.7 0.27 6.5 0 .0  CO 
0.31 0.27 14.24 2.27 0.41 0 .0  
8 * 225.6 4 .61 7.33 0.63 192.8 79.0 0.41 14.9 6 .7  2.22 
0.22 0.46 16.43 5.16 0.67 1.01 
15 X 229.2 11.65 7.17 1.62 310.7 183.3 0 .59 0 .0  11.3 0 .0  
0.33 0.21 19.13 9.51 0 .0  0.73 
8 X 231.5 14.62 8 .75 1.63 254.5 193.4 0 .76 21.6 69.6 0.44 
"2 0.36 0.51 11.52 8 .72 1.79 2.15 
Chart 5. Means and standard errors of means for operative group number 1 (0^) 
Treat­
ment 
group 
No, of 
expéri­
menta I 
anima Is 
(1) 
Pertinent 
statistic 
Fina 1 
anima 1 
weight 
(gms.) 
( 2 )  
100 gms. 
B.W. 
(mgm) 
( 2 )  
^DNA 
100 gms. 
B.W. 
per Ratio 
•RNA' DNA 
(3) 
TPN per 
100 mgns. 
M.T. 
(3) 
TPKH per 
100 mgms. 
M.T. 
(3) 
DPN per 
(3) 
DPNH per Ratio uiii L
IPNH/TPN 100 mgms. 100 =gras 
M.T. M.T. 
Ratio 
DPN/DPNH 
6 215.7 1.65 1.97 0.84 761.7 236.7 0.31 15.7 0.0 ra 
=x +0.25 +0.36 +27.61 +13.65 +3.51 0.0 
8 X 227.4 1.36 2.05 0.66 465.6 451.6 0.97 0.0 27.6 0.0 
=x 0.51 0.48 13.06 27.92 0.0 3.27 
8 X 229.7 0.87 1.87 0.47 502.5 356.8 0.71 29.6 12.7 2.33 
s-
X 
0.33 0.27 13.72 21.16 3.16 2.64 
8 X 236.5 2.79 2.85 0.97 229.7 296.3 1.29 29.5 6.7 4.40 
0.31 0.31 9.27 20.57 7.09 0.92 
Figure 20. Mammary gland from an 0 rat hormonally treated with E, P, 
STH and M 
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Figure 21, Mammary gland from an adrena lectomized receiving 
no hormonal treatment 
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Figure 22. Mammary gland from an A -0 rat hormonally treated with E 
_ _ j  n  X X  
Figure 23. Mammary gland from an A -0 rat hormonally treated with E, P, 
D and H 
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Figure 24. Mammary gland from an A -0 rat hormonally treated with 
P, D, H and T 
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Figure 25. Mammary gland from a hypophysectomized rat 
receiving no hormonal treatment 
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Figure 26. Mammary gland from a typical rat for all hormonal 
treatments 
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b. This subgroup, receiving as hormonal therapy E and P, 
had mean and ratio values of 1.36, 2.05, 0.66, 464.6, 541.6, 0.97, 0.0, 
27.6, and 0.0. Due to similarities in the extent of glandular prolifera­
tion, the remainder of this group is best represented histologically by 
Figure 26. 
c. T^ This subgroup had'mean and ratio values of 0.87, 1.87, 
0.47, 502.5, 356.8, 0.71, 29.6, 12.7, and 2.33. The hormonal treatment 
consisted of E, P, and T. 
d. Tg The mean and ratio values of this subgroup, receiving E, 
P, STH, M, and T, were 2.79, 2.85, 0.97, 229.7, 1.29, 29.5, 6.7, 4.40 
5. Hyposectomized animals (0^) 
The results of this operative group are given in Chart 6. 
a. This subgroup as shown in Figure 27, had mean and ratio 
values of 1.39, 1.66, 0.84, 637.7, 223.2, 0.35, 19.5, 5.1 and 3.82. 
b. T^ The mean and ratio values of this subgroup were 1.36, 
1.72, 0.79, 816.3, 375.5, 0.48, 36.1, 0.2, and 3.92. Again, due to 
histological similarities, the remainder of this group is best illustrated 
by Figure 28. 
c. T^ This subgroup had mean and ratio values of 1.58, 1.65, 
0.96, 705.6, 190.5, 027, 29.5, 7.6, and 3.88. 
d. T^ This subgroup had mean and ratio values of 0.77, 1.45, 
0.53, 427.6, 188.1, 0.44, 31.7, 12.9, and 2.46. The hormonal treatment 
of this subgroup was E, P, DCA., HCA, and T. 
e. Tg The mean and ratio values of this subgroup were 2.39, 
Chart 6. Means and standard errors of means for operative group number 1 (0^) 
(1) (2) (2) (3) (3) (3) (3) 
Treat­ No. of Pertinent F ina 1 
'^RNA '^DNA 
Ratio TPN per TPNH per Ra t io DPN per DPNH per Ratio 
ment expéri­ statistic anima 1 
'^RKAADNA 100 mgms. 100 mgms. TPN'H/TPN 100 mgms. 100 mgas. DPN/DPNH 
group menta 1 weight 100 gins. 100 gms. M.T. M.T. M.T. M.T. 
anima Is (gms.) B.W. B.W. 
(mgm) 
Tl 6 X 207.5 1.39 1.66 0.84 637.7 223.2 0.35 19.5 5.1 3.82 
=x ±0.37 ±0. 15 +21.65 +15.09 +3.62 +0.07 
I; 8 X 200.2 1.36 1.72 0.79 816.3 375.5 0.47 36.1 9.2 3.92 
9- 0.41 0.36 42,15 27.28 4.01 0.41 
T3 8 X 197.0 1.58 1.65 0.96 705.6 190.5 0.27 29.5 7.6 3.88 
s_ 0.29 0.42 31.27 13.17 3.97 0.39 
T5 8 X 157.2 0.77 1.45 0.53 427.6 188.1 0.44 31.7 12.9 2.46 
0.46 0.21 19.88 15.42 4.15 0.46 
Tg 9 X 232.4 2.39 2.42 0.99 316.5 364.0 1.15 31.6 5.4 5.85 
8. 
X 
0.41 0.35 17.52 27.49 2.46 0.15 
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Figure 27. Mammary gland from a rat receiving no hormonal treatment 
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Figure 28. Mammary gland from a typical rat for ail hormonal 
treatments 
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2.42, 0.99, 316.5, 364.0, 1.15, 31.6, 5.4, and 5.85. 
6. Adrenalectomized-hypophysectomized animals (0^) 
The results of this operative group of animals are given in Chart 
7. This group consisted of only one treatment subgroup, T^, the mean 
and ratio values of this subgroup were 1.29, 1.51, 0.85, 629.5, 163.7, 
0.26, 15.1, 1.7, and 8.88. (See Figure 29). 
7. Adrenalectomized-hypophysectomized-ovarectomized animals (0^) 
The results for this operative group are shown in Chart 8 . 
a. T The mean and ratio values of this subgroup were 1.45, 
2.05, 0.71, 765.8, 275.7, 0.36, 0.0, 39.7, and 0.0. For histological 
representation, see Figure 30. 
b. T^ The mean and ratio values of this subgroup were 1.11, 
1.90, 0.58, 775.6, 219.6, 0.28, 0.0, 4.4, and 0.0. Treatments T^ 
through T^ "are typical of the extent of proliferation as shown in Figure 
2 1 .  
c. T^ This subgroup had mean and ratio values of 1.05, 1.55, 
0.68, 975.9, 351.3, 0.36, 28.9, 7.0, and 4.13. 
d. T^ The mean and ratio values of this subgroup were 0.63, 
1.67, 0.38, 756.0, 310.0, 0.41, 39.9, 11.4, and 3.50. 
6. Tg This subgroup, receiving as hormonal therapy E, P, 
DCA, HCA, M, and T, had mean and ratio values of 3.69, 3.54, 1.04, 
559.7, 442.2, 0.79, 25.4, 3.2, and 7.94. Proliferation is shown 
histologically in Figure 32. 
f. Tg This subgroup had mean and ratio values of 6.01, 6.03, 
Chart 7. Means and standard errors of means for operative group number 1 (0^) 
(1) (2) (2) (3) (3) (3) (3) 
Treat­ No, of Pertinent F ina 1 
RNA' DXA 
TPN per TPKH per Ratio DPN per DPNH per Ratio 
ment experi­ statistic anima 1 100 mgms. 100 mgms. TPNH/TPN 100 mgms. 100 mg:3S. DPN/DPNH 
group mental I 
anima Is 
weight 
(gms.) 
100 gras. 100 gms. 
B.W. B.W. 
(mgm) 
M.T. M.T. M.T. M.T. 
T 6 X 215.6 1.29 1.51 0.85 629.5 163.7 0.26 15.1 1.7 8.88 
^ s. +0. 15 +0.21 +26.30 +10.15 +0.25 +0.01 
chart 8. Means and standard errors of means for operative group number 1 (0^) 
(1) 
Treat- No. of Pertinent 
ment experl- statistic 
group mental 
anima Is 
Fina 1 
anima 1 
weight 
(gms.) 
( 2 )  
P" 
100 gms. 
B.W. 
(mgm) 
( 2 )  
^DNA 
100 gms. 
B.W. 
Ratio 
'^ rna/^ DNA 
(3) 
TPN per 
100 mgms. 
M.T. 
(3) 
TPMl per 
100 mgms. 
M. I. 
Ratio 
TPNH/TPN 
(3) 
DPN per 
100 mgms. 
M.T. 
(3) 
DPNH per Ratio 
100 mgms. DPN/DPNH 
M.T. 
9 
10 
10 
19 
10 
4o 
6 X 227.6 1.43 2.05 0.71 765.8 275.7 0.36 0.0 39.7 0.0 
«X +0.21 +0.15 +19.73 +13.51 0.0 +1.72 
8 X 173.3 1.11 1.90 0.58 775.6 219.6 0.28 0.0 4.4 0.0 
S- 0.36 0.17 27.27 14.26 0.0 0.46 
8 X 182.6 1.05 1.55 0.68 975.9 351.3 0.36 28.9 7.0 4.13 
0.15 0.21 31.15 16.42 1.79 0.71 
8 X 128.5 0.63 1.67 0.38 756.0 310.0 0.41 39.9 11.4 3.50 
»x 0.25 0.27 31.71 16.79 3.51 1.57 
8 X 128.5 3.69 3.54 1.04 559.7 442.2 0.79 25.4 3.2 7.94 
s . 
X 
0.34 0.23 26.92 15.29 3.36 0.51 
8 X 107.1 6.01 6.03 1.00 427.6 517.4 1.21 19.6 2.9 6.76 
s- 0.23 0.19 21.42 27.71 2.15 0.19 
10 X 215.8 2.74 2.91 0.94 146.5 301.8 2.06 15.5 2.5 6.20 
s- 0.19 0.37 11.15 21.09 0.59 0.27 
8 X 236.2 2.79 2.68 1.04 159.6 349.5 2.19 14.6 2.7 5.41 
s- 0.27 0.15 19.25 22.15 0.67 0.71 
18 % 224.0 2.76 2.80 0.99 152.5 325.7 2.14 14.8 2.6 5.69 
8- 0.25 0.31 17.01 22.07 0.63 0.51 
Ln 
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Figure 29. Mammary gland from an rat receiving no hormonal 
treatment 
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Figure 30. Mammary gland from a A -H -0„ (T ) rat receiving no hormonal 
_ • A* X A A 
treatment 
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Figure 31. Mammary gland from a typical T rat hormonally treated with 
E and P, E, P, DCA and HCA or E, P, DCA, HCA and T 
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Figure 32. Mammary gland from a rat hormonally treated with E 
DCA, HCA., STH and T 
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1.00, 427.6, 517.4, 1.21, 19.6, 2.9, and 6.76. The hormonal therapy 
of this subgroup was E, P, DCA, HCA, M, and T. (See Figure 33). 
"^10 
The purpose of defining two separate subgroups, Tand T^^, as 
given in Chart 8 , was to test the differences due to the injection of 
growth hormone (STH) for 10 and 19 days. The experiment was designed 
to test the effect of any protein-antibody reaction with prolonged 
injection of STH. A comparison of the RNA values, using the "t" test 
(166), was found to be insignificant, probability (Prob.) < 0.50. The 
probabilities when comparing DNA, TPN, TPNH, DPN, and DPNH for the two 
injection periods were Prob. < 0.50, Prob. < 0.50, Prob. < 0.10, 
Prob. < 0.30, and Prob. < 0.50, respectively; therefore, showing no 
difference in any of the six measured substance for the two different 
injection periods. The data from these two experimental periods were 
pooled, since no differences existed, and are represented as one 
operative-treatment subgroup, 0^ - T^^, as shown in Chart 8 . The mean 
and ratio values of this subgroup were 2.76, 2.80, 0.99, 152.5, 325.7, 
2.14, 14.8, 2.6, and 5.69. The complete hormonal therapy of this 
combined subgroup was E, P, DCA, HCA, STH, M, and T. Visually, the two 
groups are shown in Figures 34 and 35. 
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Figure 33. Mammary gland from a rat hormonally treated with E, P, 
DCA, HCA, M and T 
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Figure 34. Mammary gland from a rat hormonally treated for ten days 
with E, P, DCA, HCA, STH, M and T 
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Figure 35. Mammary gland from a T rat hormonally treated for nineteen 
days with E, P, DCA, HCA, STH, M and T 
74 
V. STATISTICAL EVALUATION 
A. Natural Mamraogenesis 
A plot of the mean values for normal pregnancy and lactation for 
each of the measured substances and the three ratio values through time 
are shown in Figures 36 through 38. These figures illustrate the 
N 
sequential or time-trend variation of the normal pregnant ( P^) and the 
N 
normal lactating ( L^) animal, where or L^ indicates the day of 
pregnancy or lactation, respectively, when the values were sampled. 
Figure 36 shows as a scattergram the variation of total RNA and DNA 
per 100 grams of body weight and the ratio of RNA to DNA for the two 
investigated physiological periods. Figures 37 and 38 show, likewise 
as scattergrams, the variations of TPN and TPNH, DPN and DPNH per 100 
mgms of mammary tissue (wet weight), and the ratio values of TPNH/TPN 
and DPN/DPNII. While the scattergrams of the RNA, DNA, and RNA /DNA ratio 
values suggest monotone increasing functions as the animal progresses 
through pregnancy and lactation, it should be noted that the other 
scattergrams represent both increasing and decreasing polynomial func­
tions with, in some cases, marked variations between adjacent time 
periods. 
In order to test for the degree of variation between the correspond­
ing time periods, i.e., P^ and/or L^, pair-wise statistical comparisons were 
determined by the "t" test. The significance levels for the time-period 
comparisons are given in Table 2. After a brief review of Table 2, it 
is immediately obvious that most of the periods, in regard to the measured 
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Table 2. Significance levels from T-test of paired comparisons for time periods during pregnancy and 
lactation^ 
Physio logics 1 Physiological time periods 
time periods 
"^5 '^0 "^5 "^20 "ho 2 0 
1. RNA and DNA s ignifica nee levels 
DNA RNA 
S.5 S.5 H.S. H.S. H.S. H.S. H.S. H.S. H.S. 
N.S. N.S. H.S. H.S. H.S. H.S. H.S. H.S. H.S. 
N S.5 S.5 — — H.S. H.S. H.S. H.S. H.S. H.S. H.S. 
H.S. H.S. H.S. — — H.S. H.S. H.S. H.S. H.S. H.S. 
H.S. H.S. H.S. S.5 — — H.S. H.S. H.S. H.S. H.S. 
H.S. H.S. H.S. S.l N.S. H.S. H.S. H.S. H.S. 
H.S. H.S. H.S. H.S. S.l S.l H.S. H.S. H.S. 
H.S. H.S. H.S. H.S. H.S. H.S. N.S. S.5 H.S. 
H.S. H.S. H.S. H.S. H.S. H.S. N.S. N.S. — — S.l 
H.S. H.S. H.S. H.S. H.S. H.S. N.S. N.S. N.S. — — 
20 
2. TPN and TPNH significance levels 
TPNH TPN 
H.S. H.S. H.S. H.S. H.S. H.S. H.S. H.S. H.S. 
^H.S., highly significant , i.e., P < 0.001. 
S.l., significant at P < 0.01, P > 0.001. 
S.5, significant at P < 0.05, P > • 0.01. 
N.S., non-significant, i.e., P > 0.05. 
, no va lues . 
Table 2, (Continued) 
Physiological Physiological time periods 
time periods 
'^ 0 "h "s "ho '^ 5 ^2 0 
"r. 
H.S. — — H.S. H.S. H.S. H.S. H.S. H.S. N.S. H.S. 
K H.S. H.S. — - H.S. H.S. H.S. N.S. N.S. H.S. H.S. 
S.l H.S. H.S. ~ — H.S. S.l H.S. H.S. H.S. H.S. 
H.S. S.l S.l H.S. — — H.S. H.S. H.S. H.S. H.S. 
H.S. N.S. H.S. H.S. H.S. H.S. S.l H.S. H.S. 
"L 
H.S. H.S. H.S. H.S. H.S. H.S. N.S. H.S. H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
S.l 
H.S. 
H.S. 
N.S. 
H.S. 
^2 0 
3. DPN and DPNH significance leveIs 
DPNH DPN 
.. .. _ _  .. .. 
H.S. H.S. H.S. H.S. H.S. H.S. H.S. H.S. H.S. 
H.S. N.S. — — H.S. H.S. H.S. N.S. N.S. H.S. H.S. 
S.l S.5 H.S. — — H.S. H.S. H.S. H.S. H.S. H.S. 
S.l N.S. S.l N.S. N.S. S.l H.S. N.S. H.S. 
H.S. S.l H.S. H.S. H.S. S.5 S.l N.S. H.S. 
1 
S.l 
H.S. 
S.5 
N.S. 
H.S. 
N.S. 
S.l 
H.S. 
H.S. 
N.S. 
H.S. 
H.S. 
H.S. 
H.S. 
S.5 
H.S. 
H.S. 
S.l 
S.5 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
H.S. 
N.S. 
H.S. 
N.S. 
H.S. 
H.S. 
S.5 
S.l 
S.5 
H.S. 
H.S. 
H.S. 
4o 
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substances, are highly significantly (H.S,) different from each other. 
However, from Table 2 , we must note that N when compared to Np 
5 10 
is the only case of non-significant (or similar) RNA concentrations: 
N versus (-) N , N - N , N - N , N - N , N - N , 
C ^20 1 5 10 ^5 15 5 20 
N - N , N - and N - N are cases of insignificant DNA 
^10 15 10 20 15 20 
concentrations; N - N , N - N , N - N ., N - N and 
^5 15 10 ^5 10 10 5 10 
N - N show similar TPN concentrations; N - is the only 
^10 ^20 5 1 
example of similar TPNH concentrations; N - N , N - , 
10 ^5 10 10 
Nq - N , N - , N. - N. and N - N for like (or 
20 1 20 15 1 15 5 10 
insignificant) DPN concentrations; and N - N , N - N , 
5 10 5 20 
N_ - N , N„ - N , N - Np , and N - N for non-significant 
5 10 10 10 15 20 5 15 
DPNH concentrations. A summarization of the insignificant time-period 
groupings, as shown by the mean values and as determined by pair-wise 
comparisons, is given in Table 3. In this table those means connected 
by the undermark are insignificant; otherwise significantly different 
from each other. 
B. Artificial Mammogenesis 
In order to measure the extent of artificial mammogenesis, reports 
N 
use the 20th day of normal pregnancy ( ^20^ the major testing criterion. 
In accordance with the use of this a priori condition for estimating the 
extent of artificial mammogenesis, all experimentally ablated and/or 
Table 3 . Groupings of insignificant means for measured time-periods, pregnancy and lactation 
Measured Ranked mean values 
substance 
RNA 1.12 1.68 1.86 3.38 6.16 10.28 16.23 23.67 26.80 31.17 
N N N N N N N N N N 
^ J_5 ^ 15 20 1 5 10 15 20 
DNA 3.20 3 . 4 2  4 . 3 2  6.62 7.90 8.49 10.47 10.59 10.43 11.07 
N N N N N N N N N N 
^ ^5 10 15 20 ^1 5 10 ^15 20 
TPN 24.6 43.6 76.4 80.6 104.8 135.9 2 4 7 . 4  277.1 406.1 525.8 
N N N N N N N N N N 
^15 1 5 10 10 4o 15 5 ^20 
TPNH 298.4 373.3 557.6 559.7 678.2 851.1 1146.0 1700.1 2002.7 5851.0 
N N N N Np N N N N N 
^15 ^1 ^ 20 10 5 20 10 15 
DPN 0.0 51.1 154.1 269.1 285.7 292.0 359.2 387.4 397.4 4 9 6 . 9  
'c "h \ "^ 0 '^ 10 '^ 5 
DPNH 2.9 4.2 4.5 6.1 7.3 8.3 11.1 12,8 16.8 24.6 
N N N N N N N N N N 
^1 Ho ^10 5 20 15 5 15 Ho 
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hormonally injected animals were compared to the proper N value. 
2 0 
To test the extent of artificial maramogenesis, the experimental 
animals were stratified into two different groupings, i) by operative 
group regardless of treatment group, i.e. , all animals being in the same 
operative state (Charts 2 through 8), and ii) by treatment group regard­
less of operative group, i.e., all experimental animals receiving the 
same hormonal injection; see Table 4. This stratification was done in 
the attempt to extract more information from the experimentation. The 
stratified groups were statistically tested by Dunnett's test (166), 
chosen for the following three reasons: 
i) Analysis of the experimental data by the appropriate analysis 
of variance model, not shown herein, showed a high degree of 
variation within treatment groups, operative groups and their 
interaction; this suggested a comparison of means was necessary 
to gain insight into individual treatment and/or surgical 
difference. 
ii) Analysis of the experimental data by paired comparisons, i.e., 
multiple "t" tests, would be in appropriate due to an insuf­
ficient number of total degrees of freedom, i.e., the number of 
needed comparisons exceeded the total available degrees of 
freedom. 
iii) Analysis of the data by a multiple range test, such as the 
Duncan test, would give unnecessary comparisons--since the 
literature uses N as an £ priori criterion, and would be 
20 
inappropriate due to the insufficient number of degrees of 
freedom. 
83 
The mean values of the operative groups regardless of treatment group 
and the pooled variances necessary for the Dunnett test procedure are 
shown in Tables 4 and 5, respectively. Table 5 also gives the 95% 
and 99% confidence intervals of the control N , for each operative-
2 0  
treatment group. Related figures give a graphic representation of the 
results from the Dunnett test, and Table 6 gives a summary of the data 
represented in these figures. 
1. RNA comparisons 
Upon inspection of the results from the Dunnett test as shown in 
Figures 39 and 40, it is immediately apparent that 0^ - T^ is the only 
operative-treatment combination group that has RNA values insignificantly 
different from N . However, if one studies Figures 39 and 40, along 
20 
with Table 6, one will notice that, 
a. 0^ without hormonal therapy tended to increase the RNA concen­
tration of the mammary gland, but was less than the RNA con­
centration at N 
2 0  
b. 0^ and/or 0^ with hormonal therapy usually tended to increase 
the RNA concentration of the gland above that of N 
2 0  
c. 0^ with hormonal therapy tended to increase the RNA concentration 
such that it was approximately equivalent to N 
2 0  
d. Hypophysectomy tended to lower the RNA concentration of the 
gland--regardless of additional surgery, i.e., 0^, 0^, 0^ 
and Oy--without hormonal therapy or with hormonal therapy when 
STH and/or M were excluded from the therapy from that of N ; 
20 
however, when STH and/or M were included in the therapy, the 
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Table 4. Means by operative group within treatment group 
Treat- Operative Number 
ment group of 
group experi- Measured substance 
raenta1 
anima Is RNA Dm TPN TPNH DPN DPNH 
T, 12 1.12 3.20 525.8 373.3 0.0 2 4 . 6  i 
°2 6 1.20 3.12 432.0 155.5 70.7 8.4 
6 4.06 3 . 9 5  176.8 47.7 6.5 0.0 
0 ^  6 1.65 1 . 9 6  761.7 2 3 6 . 7  15.7 0.0 
6 1.39 1.66 637.7 223.2 19.5 5.1 
6 1.29 1.51 6 2 9 . 5  163.7 15.1 1.7 
6 1.45 2.05 7 6 5 . 8  2 6 5 . 6  0.0 39.7 
T. 0. 8 3.87 6 . 0 0  317.1 301.2 215.2 3.1 
z o] 19 4 . 7 8  7 . 2 4  2 00.5 192.5 15.6 1.5 ol 8 4.61 7.33 1 9 2 . 8  79.0 14.9 6.7 
0 ?  8 1.36 2.05 4 6 5 . 6  451.6 0.0 27.6 
0^ 8 1.36 1.72 8 1 6 . 3  375.5 36.1 9.2 
°7 8 1.11 1.90 775.6 219.6 0.0 4.4 
0, 8 8.71 7 . 8 8  3 2 8 . 1  275.6 290.2 3.4 
J 
°2 17 15.40 9.40 231.8 2 5 9 . 6  19.8 9.4 
8 0.87 1 . 8 7  502.5 3 5 6 . 8  2 9 . 6  12.7 
4 
8 1.58 1.65 605.6 190.5 29.5 7.6 
T, 0. 8 6.11 5.65 209.5 2 8 2 . 8  91.0 0.0 
4 
°2 19 10.31 6.77 248.5 226.1 0.0 14.4 
15 11.65 7.17 310.7 183.3 0.0 11.3 
4 
8 1.05 1.55 975.9 351.3 2 8 . 9  7.0 
T, 0, 8 6 . 8 7  5 . 9 7  399.0 367.1 145.8 0.0 
5 
03 8 14.62 8 . 7 5  254.5 193.4 21.6 4 9 . 6  
°5 8 0.77 1.45 4 2 7 . 6  188.1 31.7 12.9 
°7 8 0.63 1.67 756.0 310.0 3 9 . 9  11.4 
T. 0. 8 9.30 6. 66 215.6 247.9 307.5 3.7 0 0, 8 2.79 2.85 2 2 9 . 7  2 9 6 . 3  29.5 6.7 
4 
9 2.39 2.42 316.5 364.0 31.6 5.7 
^ 7  «2 
8 15.65 8 . 4 2  236.7 416.6 15.9 7 . 8  
^8 ° 7  
8 3.69 3.54 559.7 442.2 25.4 3.2 
^9 O 7  
8 6.01 6.03 427.6 517.4 19.6 2.9 
^10 O 7  18 2.76 
2.80 152.5 325.7 14.8 2.6 
Table 5. Pooled variances and confidence intervals from Dunnett's procedure 
Comparison Degrees (1) (2) 
(N verses) of p Pertinent Measured substance 
20 freedom value statistic RM DMA TPN TPNH DPN DPNH 
h 4 8  7 s  p 0 . 2 9  0.24 2 0 . 0 6  14.14 3.55 1.00 
95% C.I. 
99% C.I .  
0.45 
0.54 
0.36 
0.44 
29.91 
3 6 . 2 6  
21.09 
25.55 
5.30 
6.42 
1.48 
1.79 
h 60 6 s  p 0 . 3 8  0 . 3 8  20.79 17.90 4.74 0.87 
95% C.I .  
99% C.I .  
0.59 
0.72 
0.59 
0.72 
3 2 . 4 0  
3 9 . 3 6  
27.89 
3 3 . 8 8  
7.40 
8.99 
1.35 
1.64 
h 44 4 s  P 
95% C.I .  
99% C.I .  
0.39 
0.72 
0.90 
0.32 
0.59 
0.74 
1 9 . 4 8  
45.67 
5 6 . 8 6  
18.14 
32.98 
4 1 . 0 6  
7.90 
14.37 
17.89 
0.90 
1.64 
2.05 
53 4 s  
P 
95% C.I .  
99% C.I .  
0.30 
0 . 5 4  
0.67 
0.32 
0.59 
0.73 
17.74 
32.10 
39.73 
17.33 
31.36 
3 8 . 8 3  
4.83 
8 . 7 6  
10.84 
0.80 
1.46 
1.81 
^5 35 4 s  p 0.38 0.34 18.69 16.85 7.27 1.24 
95% C.I .  
99% C.I .  
0.70 
0 . 8 8  
0 . 6 2  
0.78 
34.37 
4 2 . 9 6  
3 0 . 9 7  
38.71 
13.36 
16.70 
2.29 
2 . 8 6  
^6 29 3 s  p 0.39 0.33 
15.50 21.01 9.65 0.48 
95% C.I .  
99% C.I .  
0.80 
1.01 
0.65 
0.82 
31.65 
40.13 
4 2 . 8 8  
54.37 
19.70 
24.98 
0.98 
1.24 
^7 14 1 s p 
0.46 0.34 14.05 20.05 9.03 0.76 
95% C.I .  
99% C.I .  
0.14 
0.21 
0.11 
0.15 
4.26 
5.93 
6 . 0 8  
8.46 
2.74 
3.81 
0.24 
0 . 3 3  
I 
I 
Table 5. (Continued) 
Comparison Degrees (1) (2) 
(N verses) of p Pertinent 
20 freedom value statistic 
Ta 14 1 Sp 
95% C.I. 
99% C.I. 
T g  1 4  1  S p  
95% C.I. 
99% C.I. 
TlO 24 1 Sp 
95% C.I. 
99% C.I. 
0, 53 6 s 
1 P 
95% C.I. 
99% C.I. 
0 ,  7 1  5  S p  
95% C.I. 
99% C.I. 
0^ 40 4 Sp 
95% C.I. 
99% C.I. 
O4 33 4 Sp 
95% C.I. 
99% C.I, 
RNA DNA 
Measured substance 
TPN TPNH DPN DPNH 
0.40 0.30 21.28 39.14 10.12 0.64 
0 . 1 3  0.09 6.44 11.83 3.06 0.19 
0.18 0.12 8.97 16.48 4 . 2 6  0.27 
0.34 0.28 17.54 25.34 9.52 0.48 
0.11 0.09 5.61 7 . 6 6  2.89 0.15 
0.15 0.12 7.81 10.67 4.02 0 . 2 1  
0.34 
0.10 
0.14 
0.32 
0 . 1 0  
0.04 
15.52 
4.51 
6.13 
22.30 
6 . 4 9  
8 .8 2  
8 . 7 8  
2.55 
3.46 
0 . 6 2  
0.19 
0.25 
0 . 3 6  0.33 16.17 16.05 11.14 1.06 
0.57 0 . 5 2  25.38 2 5 . 2 1  17.49 1 . 6 6  
0.70 0 . 6 3  30.89 30.68 21.28 2.02 
0.36 0.32 15.12 19.73 5.32 0.72 
0.60 0.54 25.14 3 2 . 8 2  8.97 1.21 
0.74 0.62 30.69 40.06 10.79 1.48 
0.33 0.37 15.40 9.73 3.95 0.93 
0.59 0.67 28.10 17.75 7.20 1.70 
0.74 0 . 8 3  34.96 2 2 . 0 8  8 . 9 6  2.12 
0.38 0.36 15.87 21.26 6 . 1 3  1 . 5 2  
0.68 0.65 29.28 39.23 11.30 2.79 
0 . 8 5  0.82 3 6 . 5 8  50.00 14.12 3.49 
Table 5. (Continued) 
Comparison Degrees (1) (2) 
(N verses) of p Pertinent Measured substance 
20 freedom value statistic RNA DNA TPN TPNH DPN DPNH 
0^ 41 
0, 12 
b 
0^ 63 
Notes : 
(1) p-value is the number of treatment means being compared, excluding the control. 
(2) Sp is the pooled standard error of the combined treatment and control groups. 
957o C.I. is the 95 percent confidence interval of the control mean, +. 
997a C.I. is the 99 percent confidence interval of the control mean, +. 
s 
p 
0.40 0.31 2 4 . 6 9  20.24 5 . 8 5  0.37 
95% C.I. 0.67 0.53 41.68 34.18 9 . 8 8  0.61 
99% C.I. 0.82 0 . 6 6  51.36 42.11 12.17 0.76 
s 
p 
0.30 0 . 3 0  20.98 16.56 8 . 5 7  0 . 3 8  
95% C.I. 0 . 0 9  0.09 6.47 5 . 1 0  2.64 0.13 
99% C.I. 0.12 0.12 9 . 0 6  7.14 3.69 0.18 
s 
p 
0.27 0.24 22.70 18.82 3.22 0.77 
95% C.I. 0.39 0 . 3 6  33.48 27.77 4.75 1.13 
99% C.I. 0.47 0 . 4 3  4 0 . 3 9  33.50 5.73 1.37 
Table 6. Summarization of results from Dunnett test procedure 
(1) (2) 
Primary strata C.I. of control Results of Dunnett comparison (N verses) 
(T.) (0 ) (Np ) 120 
20 Non-significantly Significantly different groups 
95% 99% different groups Group means less Group means greater 
1. RNA. (N = 6.16 mgms Total RNA per 100 gms body weight) 
2 0  
T 5.71-6.61 5.62-6.70 all 
T, 5.56-6.75 5.44-6.88 all 
T^ 5.44-6.88 5.26-7.06 0, & 0 0,0, & 0 
T, 5.62-6.70 5.49-6.83 0 0 0„ & 0_ 
5.46-6.86 5.28-7.04 0:,0 & 0 0 
5.36-6.96 5.15-7.17 0^ & 0 0^ 
6.02-6.30 5.95-6.37 0. 
l' 6.03-6.29 5.98-6.34 0 
Tq 6.05-6.27 6.01-6.31 o' 
6.06-6.26 6.02-6.30 o' 
^ 0 5.59-6.73 5.46-6.86 T T: & T T ,T & T, 
0, 5.56-6.76 5.42-6.90 T: & T T^,T, & T 
0^ 5.57-6.75 5.42-6.90 & T T^ & T 
0^ 5.48-6.84 5.31-7.01 all 
0^ 5.49-6.83 5.34-6.98 all 
0^ 6.07-6.25 6.04-6.28 T 
0^ 5.77-6.55 5.69-6.63 T^ all others 
2. DNA (N =7.90 mgms Total DNA per 100 gms body weight) 
20 
T 7.54-8.26 7.46-8.34 all 
T^ 7.31-8.49 7.18-8.62 0 all others 
7.31-8.49 7.16-8.64 O:? 0, & 0, 0, 
T^ 7.31-8.49 7.17-8.63 all others 
7.28-8.52 7.12-8.68 0 ,0 & 0 0 
7.25-8.55 7.08-8.72 all 
b 
Table 6. (Continued) 
(1) (2) 
Primary strata C.I. of control Results of Dunnett comparison (N verses) 
(T.) (0.) (NP ) 2^0 
20 Non-significantly Significantly different groups 
95% 99% different groups Group means less Group means greater 
10 
Or 
7.79-8.01 
7.81-7.99 
7.81-7.99 
7.80-8.00 
7.38-8.42 
7.36-8.44 
7.22-8.57 
7.25-8.55 
7.37-8.43 
7.81-7.99 
7.54-8.26 
7.75-8.05 
7.78-8.02 
7.78-8.02 
7.76-8.04 
7.27-8.52 
7.25-8.55 
7.07-E 
7.08-E 
7.24-E 
7.78-E 
7.47-E 
.73 
.72 
.56 
. 02  
.33 
ail others 
Tl'Tg & ^4 
?! & ^4 
all 
all 
all 
10 
01 
3. TPN (N = 406.1 
2 0 
376.2-436.0 369.8-442.4 
373.7-428.5 366.7-445,5 
360.4-451.8 349.2-461.0 
374.0-437.2 366.4-445.8 
371.7-440.5 363.1-449.1 
374.5-437.7 366.0-446.2 
401.8-410.4 400.2-412.0 
399.7-412.5 397.1-415.1 
400.5-411.7 398.3-413.9 
401.6-410.6 400.0-412.2 
380.7-431.5 375.2-437.0 
381.0-431.2 375.4-436.8 
378.0-434.2 371.1-441.1 
376.8-435.4 369.5-442.7 
364.4-447.8 354.7-456.5 
jiM per 100 mgms mammary tissue) 
0, & 0, 
°3 
o:\o_ & 
0 & 0 
ou.o, & 
o;  
0 3 
all 
2 ' 3' 4 
all' 
all others 
0 ,0 & 0 
.Tg & T 
.T, & T, 
Table 6. (Continued) 
(1)  , 
Primary strata 
( 2 )  
C.I. of control 
(T.) (Oi) (Np ) 
2 0  
95% 99% 
Results of Dunnett comparison (N verses) 
^20 
Significantly different groups 
Group means less Group means greater 
Non-significantly 
different groups 
399.6-412.6 
372.6-439.6 
397.0-415.2 
365.7-446.5 
TPNH (N = 678.2 juM per 100 mgms mammary 
2 0  
10 
tissue) 
657.1-699.3 652.6-703.8 a  1 
,1 650.3-706.1 644.3-712.1 a  1 
,2 
,3 
645.2-711.2 637.1-719.3 a  1 
646.8-709.6 639.4-717.0 a  1 
,4 647.2-709.2 639.5-716.9 a  1 
,5 635.3-721.1 6 2 3 . 8 - 7 3 2 . 6  a  1 
,6 
,7 
,8 
672.1-684.3 669.7-686.7 a l  
666.4-690.0 661.7-694,7 a  1 
679.5-685.9 667.5-688.9 a  1 
,9 
10 
671.7-684.7 669.4-687.0 a  1 
653.0-703.4 647.5-708.9 a  1 
S 645.4-711.0 638.1-718.3 a  1 
660.6-695.8 656.1-700.3 a  1 
O4 639.0-717.4 628.2-728.3 a  1 
644.0-712.4 636.1-720.3 a  1 
°6 673.1-683.3 671.1-685,3 a  1 
4  650.4-706.0 644,7-711,7 a l  
5. DPN (N = 269. 1 )_iM per 100 mgms mammary tissue) 
20 
263.8-274.4 
261.7-276.5 
254.7-283,5 
262.7-275.5 
260. 1-278.1 
251.2-287.0 
all 
all 
& 0^ 
& Tg 
Table 6. (Continued) 
(1) (2) 
Primary strata C.I. of control Results of- Dunnett comparison (N verses) 
(T.) (0.) (Np ) 20 
^20 Non-significantly Significantly different groups 
95% 99% different groups Group means less Group means greater 
• 1 0  
260.3-277.9 
255.7-282.5 
249.4-288.8 
265.4-271.8 
266.0-272.2 
266.2-272.0 
266.5-271.7 
251.6-286.6 
260.1-278.1 
261.9-276.3 
257.8-280.4 
259.2-279.0 
266.5-271.7 
264.3-273.9 
258.3-279.9 
252.4-285.8 
244.1-294.1 
265.3-272.9 
264.8-273.4 
265.1-273.1 
2 6 5 . 6 - 2 7 2 . 6  
247.8-290.4 
258.3-279.9 
260.1-278.1 
255.0-283.2 
256.9-281.3 
2 6 5 . 4 - 2 7 2 . 8  
263.4-274.8 
all 
all 
0 & 0.  
0: 
T: .T 
all 
all 
all 
all 
all 
T, & 
6. DPNH (N c: 7.3 ijM per 100 ragms mammary tissue) 
10 
5.8-8.8 
5.9-8.7 
5.7-8.9 
5.8-8.8 
5.0-9.6 
6.3-8.3 
7.1-7.5 
7.1-7.5 
7.1-7.5 
7.1-7.5 
2 0  
5.5-9.1 
5.7-8.9 
5.2-9.4 
5.5-9.1 
4.4-10.2 
6.1-8.5 
7.0-7.6 
7.0-7.6 
7.1-7.5 
7.1-7.5 
0, 
0^,0^ & 0^ 
0 ,  &  0 ,  
& 0, 0 & 0 
0 & 0 
0, & 0. 
Oo & 0% 
03,05 & 0^ 
Table 6. (Continued) 
(1) 
Primary strata 
(T^) (0.) 
( 2 )  
C.I. of control 
(Np ) 
2 0  
Results of Dunnett comparison (N verses) 
2 0  
95% 99% 
Non-significantly 
different groups 
Significantly different groups 
Group means less Group means greater 
Notes ; 
0: 
(1) 
5.6-9.0 5.3-9.3 
6.1-8.5 5.8-8.8 T & T 
5.6-9.0 5.2-9.4 
^2 
4.5-10.1 3.8-10.8 
6.7-7.9 6.5-8.1 T3 
7.2-7.4 7.1-7.5 
6.2-8.4 5.9-8.7 
"4 
= Treatment groups regardless of operative group, 
= Operative group regardless of treatment group. 
T T & T 
T & T* 
T T^ & 
& ^6 ^2 & T; 
& ?10 T1.T5 
(2) Confidence intervals associated with N as determined by the Dunnett procedure (see Table 
5). 20 
Treatment 
group Operative group 
2 
Sea le 
3 
4 
5 
6 
7 
8 
9 
10 
Scale 
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Figure 39. Graphic representation of RNA results from Dunnett's test. Stratified by treatment group 
Opera tive 
group 
1 Treatment group 
3 
4 
_7 
Sea le 
1 1 1 
1 2 4 
1 1 
1 2 
\ 1 
1 2 
1 II 1 
3 2 1 6 
IN 1 
5 1&2 3 6 
1 
1 
1 II i II 1 
5 42 1 10 8 9 
1 t \ 
5 3 6 
1 1 1 
4 3 7 
1 1 
4 5 
\ \ \ \ \ \ 1 1 
0 1 2 3 4 5 ICf 15 
Total mg of RNA per 100 gms body weight 
Figure 40. Graphie representation of RNA results from Dunnett's test, stratified by operative group 
95 
RM concentration tended to increase towards that of N , with 
20 
exerting a greater effect than STH. 
e. Any hormonal therapy tended to increase the total RNA in the 
mammary gland per 100 gras, body weight of animal for 0^, 0^ 
and 0^, such that the RNA concentration was equivalent to or 
greater than N . -
20 
f. All hormonal therapy tended to be ineffectual after hyposectomy--
with or without additional surgery, with the exception of STH 
and M; M tended to increase the RNA concentration to that of 
2. DNA concentration 
It is apparent from observation of Figures 41 and 42, and Table 6 
that 0^ - Tg, 0^ - Ty and 0^ - T^ are the only operative-treatment 
combinations that have DNA values statistically similar to Np . Addi-
20 
tional information found in the above mentioned figures and table is as 
follows : 
a. 0^, with and without hormonal therapy, tended to yield a DNA 
concentration lower than or equivalent to Np 
.  2 0  
b. 0^, with hormonal therapy, tended to produce a DNA concentra­
tion equivalent to or greater than that at N_ 
20 
c. 0^, without replacement therapy, tended to have a DNA value 
lower than that of N 
2 0  
d. 0^ tended to have a variable DNA concentration when compared 
with N , according to the therapy given. 
2 0  
e. 0^, with or without additional surgery, tended to be lower 
Treatment 
group 
Operative group 
1 
1 1 1 
6 5 4 
1 
7 
1 1 
2 1 
1 
3 
2 
1 1 
5 7 
i 
4 
1 
1 
< 1 
2 3 
1 t 
5 4 
1 
1 
I 
2 
4 
1 
7 
I 
1 
1 1 
2 3 
5 \ 1 
5 7 
1 ( 
1 
1 
6 1 
5 
1 
4 
1 
1 
7 
I 
3 
8 
9 . 
10 
1 
7 
1 
7 
1 
7 
20 
Scale 
1 
0 
\ 
1 
1 
2 
Tota 1 
1 
3 
mg of DNA 
4 
per 
1 
5 
100 gms body wei ght 
1 
10 
Figure 41. Graphie representation of DNA results from Dunnett's test, stratified by treatment group 
Operative 
Treatment group 
group 
I I I I  1  
1 1 4 2&5 6 3 
1 1 1 1 
2 1 4 2 3 
1 II 
1 4 2 
II 1 
4 31&2 6 
11 1 
5 1,2 6 
P 
1 
4%i I'o '8 9 
_7 
1 1 i 1 1 1 1 1 
-Scale 
0 12 3 4 5 10 15 
Tota1 mg of DNA per 100 gms body weight 
Figure 42. Graphie representation of DNA results from Dunnett's test, stratified by operative group 
98 
than Np 
20 
f. Any hormonal therapy tended to increase the DNA. concentration 
for 0^, 0^, and 0^, but tended to have little or no effect on 
the DNA concentration for 0^--regardless of secondary surgery. 
3. TPN concentration 
Inspection of Table 6, Figure 43 and Figure 44, shows that 0^ - , 
0^ - T^j Og - and 0^ - T^ give TPN values statistically analogous to 
Np . Trend effects are as follows: 
20 
a. 0^, without therapy, tended to produce a TPN concentration 
greater than N ; with therapy, tended to be lower than or 
^20 
equivalent to the TPN concentration at N 
2 0  
b. 0^, without hormonal replacement, like 0^, tended to have a 
higher TPN value than N ; with therapy, the TPN values were 
2 0  
in all cases lower than the TPN value at N 
2 0  
c. 0^, with or without hormonal therapy, tended to be lower than 
the TPN value at N 
2 0  
d. Hypophysectomy did not seem to offer the primary effect on 
TPN as it did with RNA and DNA, producing variable, i.e., low 
and high, TPN values when compared to N 
20 
e. T^ in all cases except 0^ tended to increase TPN values above 
that at N 
2 0  
f. Tg and T^ tended to decrease the TPN concentration below that 
at N with 0,, 0, and 0„; however, these treatments tended 
20 
to increase the TPN values above that of N when hypophy-
20 
sectomy--regardless of additional surgery--was performed. 
Treatment 
group Operative group 
1 
1  
3 
1  1  1  r  
2 1 6 5 4^ 7 
2 
1  1  
3 2 
1  
1 '4 7' 5' 
1  
2 
1  
1 
1  
4 
1  
5 
4 1  
1 
1  1  
2 3 
1  
7 
5 1  
3 
1  
1 
1  
5 
6 1  1  
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1  
5 
7 1  
2 
8 1  
7 
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1  
7 
1  
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10 
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Figure 43. Graphic representation of TPN results from Dunnett's test, stratified by treatment group 
Operative 
group 
Treatment group 
_1_ 
_2_ 
4 
Sea le 
w 
4 6 
1 ni 
2 37 4 
I  I  
1 2 
I  
2 3 
J  
4 
i l  
1  I  
2 3 
/ 1  1  I I  1  
10 9 8 51 2 
^p 
400 500 LOO 200 3( 
iM of TPN per 100 mgms mammary tissue 
r 
800 
Figure 44. Graphic representation of TPN results from Dunnett's test, stratified by operative *;roup 
101 
g. Hypophysectomy, where hormonal therapy excluded M, tended 
to produce higher TPN values than those estimated at N ; 
20 
therapy including M, tended to produce values lower than or 
equivalent values to those for N 
2 0  
4. TPNH concentration 
Upon examination of Figure 45 and 46, one immediately finds no 
operative-treatment combination statistically equivalent in TPNH con­
centration to that of N . Table 6 substantiates the results and 
2 0  
indicates that all operative-treatment combinations produced TPNH values 
lower than those at N 
20  
5. DPN concentration 
The results of the Dunnett test as presented in Table 6 and Figures 
47 and 48, again show that the DPN values from all operative-treatment 
combinations are significantly different from those obtained at N 
2 0  
However, 0^ - T^ and 0^ - T^ tended to be higher in DPN concentration as 
opposed to lower for all other operative-treatment combinations when 
compared to N 
2 0 .  
6. DPNH concentration 
Investigation of the results found in Figures 49 and 50, along with 
Table 6, shows that 0^ " 0^ - T^, 0^ ~ '^2' *^4 ~ ^6' *^5 " ^ 3 
0 - T, are cases of DPNH similarity with the results of N . The 
' 20 
results from the various operative-treatment combinations were quite 
variable, and gave no insight into treatment and/or operative group 
Treatment 
group 
Operative group 
1 
1 
3 
II II 
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1 
7 
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1 
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Figure 45. Graphie representation of TPNH results from Dunnett's test, stratified by treatment group 
Operative 
eroup Treatment group 
1  1  1  1  M  
1 6 34 2 5 1 
1  1  1  1  1  
2 1 2 4 3 7 
t  1  1  1  
3 1 2 4 5 
1  1  1  1  
A _  ' I 6 3 2 
1  1  1  1  
J 3&5 1 6 2 
1  
6 1 
1  1  1  1  I  1  
7 2 1 5 10 4 8 9 
y  "  
Sea le 
1  1  
0 100 
1  
200 
/iM 
1  
300 
of TPNH 
1  
400 
per 100 mgms 
1  
500 
mammary tissue 
1  
800 
o 
Figure 46. Graphie representation of TPNH results from Dunnett's test, stratified by operative group 
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Figure 47. Graphie representation of DPN results from Dunnett's test, stratified by treatment group 
Operative 
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Figure 48. Graphie representation of DPN results from Dunnett's test, stratified by operative group 
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Operative group 
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Figure 49. Graphie representation of DPNH results from Dunnett's test, stratified by treatment group 
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Figure 50. Graphie representation of DPNH results from Dunnett's test, stratified by operative group 
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trends when compared by the Dunnett test to the DPNH value at N 
20 
Further investigation is necessary for a complete elucidation of the 
exact nature of these results. In order to attempt a tabular explanation, 
Chart 9 and Table 7 were compiled. Again using the above mentioned 
stratifications, these show the absolute effect differences resulting 
from the various treatments above (or below) that of (i.e., 0^ - T^), 
and from each other. From Chart 9 and Table 7, one is able to gain insight 
into the addition effect of particular hormones, given an operative state 
and a treatment condition. Because of the voluminous size of Chart 9 and 
Table 7, no explanation of individual effect differences or trends can 
be attempted. 
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Chart 9. Absolute treatment effects for treatments within operative groups 
C o r r e c t e d  T r e a t m e n t  d i f f e r e n c e !  - T ^  ( J  >  i )  
1  
-
• ^ I  ^ 2  ^ 6  ^ 6  h h ^ 1 0  
V .  R K X  
1  I .  1  1 3  0  n  . 2 . 7 5  * 7 . 5 9  •  5 . 9 9  •  5 . 7 5  • 8 . 1 8  
I 3 . n 7  . 3  n  •  A . « 6  0 . 3 6  •  3 . 0 0  
3  8  7 1  ,  7  5 9  - 1 . 6 0  - 1 . 8 6  •  0 . 5 9  
U 6  1  , 5  9 9  •  0 . 2 6  - 2 . 1 9  
5  8 7  . 5  7 5  - 2 . 6 3  
6  9  3 0  4 8  1 8  
-- -- --
-- --
1  I  2 0  I  1 2  ' 0  0 8  4 3 , 5 8  • 1 6 . 2 0  •  9 . 1 1  + 1 6 . 6 5  
2  U 7 6  , 1  lib • 1 0 . 6 2  •  5 . 5 3  + 1 0 . 8 7  
3  1 5  6 0  4 1 6 . 2 8  - 5 . 0 9  + 0 . 2 5  
U 1 0  3 1  « 9  1 9  + 5 . 3 6  
7  1 5  h 5  4 1 6  5 3  
-- " -- --
I  U 0 ' .  I  \1 , 2 . 9 6  •  0 . 5 5  •  7 . 5 9  • 1 0 . 5 6  
2  4  M  ' 3  6 9  •  7 . 0 6  •  1 0 , 0 1  
i* 1  1 , 5  W O . 5 3  •  2 . 9 7  
3  1 6  ( i 2  •  1 3  5 0  
-- -- -- --
1  I  ' ) 5  I  1 2  . 0  5 3  - -  .  - 0 . 2 9  - 0 . 7 8  •  1 .  1 6  
2  1  3  h  . 0  2 6  - 0 . 6 9  +  1 . 6 3  
3  0  8 7  - 0  2 5  +  1 . 9 2  
( i  2  7 9  4 l  6 7  
-- -- -- --
--
I  1  3 9  1  1 2  . 0  2  7  - 0 . 0 3  •  0 .  1 9  - 0 , 6 2  +  1 , 0 0  _ _  
2  1  3 f .  . 0  2  6  •  0 , 2 2  - 0 . 5 9  +  1 , 0 3  
3  1  5 h  . 0  6  h - 0 . 8 1  +  0 . 8 1  
5  0 . 7 7  - 0  3  5  +  1 . 6 2  
b  2  3 9  •  1 .  2  7  
--
--
--
--
1  I  2 9  1  1 2  . 0  1 7  
-- -- --
1  I  6 5  1  1 2  . 0  3 3  - 0 . 3 6  • 0 . 6 0  - 0 . 8 2  + 2 . 2 6  + 6 . 5 6  + 1 . 3 1  
2  1  l i  - 0  0 1  
- 0 . 0 6  - 0 . 6 8  + 2 . 5 8  + 4 , 9 0  +  1 . 6 5  
U I  0 5  - 0  0 7  
- 0 . 6 2  + 2 . 6 6  + 6 . 9 6  +  1 . 7 1  
5  0  " 3  - 0  6 9  + 3 . 0 6  + 5 . 3 8  + 2 . 1 3  
H  3  r , 9  • 2  5 7  + 2 . 3 2  - 0 . 9 3  
9  0 1  . 6  8 9  
- 3 . 2 5  
1 0  2  • 1  ' • 6  
2 .  D N A  
I  3  2 0  3  2 0  0 .  0  4 2 . 8 0  •  6 . 6 8  • 2 . 5 5  • 2 . 7 7  •  3 . 6 6  _ _  
2  f ,  0 0  • 2 ,  8 0  •  1 . 8 8  • 0 . 2 5  - 0 . 0 3  •  0 . 6 6  
3  7  H H  , 6  ( H  
- 2 . 1 3  - 1 . 9 1  +  1 . 2 2  
U !) 7 5  • 2  5 5  •  0 . 2 2  +  0 , 9 1  
5  5  9  7  • 2  7  7  + 0 . 6 9  
U 6  (iU • 3  6  6  
-- -- -- --
1  3  1 2  3  2 0  - 0  O H  4 6 . 1 2  • 1 2 . 2 8  •  7 . 1 9  + 1 2 . 5 3  _ _  
2  7  2 6  . 6  0 6  - •  • 6 .  1 6  •  3 . 0 7  + 8 . 6 1  
3  1 5  6 0  . 1 2  2 0  
- 5 . 0 9  + 0 . 2 5  
U 1 0  3 1  • 7  t  1  + 5 . 3 6  
7  1 5  6 5  .  1 2  6 5  
-- --
1  /. O f ,  3  2 0  . 0  8  6  * 0 . 5 5  •  7 . 5 9  • 1 0 . 5 6  .. .. 
2  z ,  ' . 1  1  6 1  +  7 . 0 6  • 1 0 . 0 1  
U I  f > 5  •  8  6 5  + 2 . 9 7  
3  U  h  2  4 \ 1 . 6 2  
--
--
--
- -
-
I  1  f , 5  3  2 0  - I  5 5  • 0 . 2 9  •  0 . 2 2  _ _  •  1 . 2 0  
2  I  -  I  8 6  •  0 . 5 1  •  1 . 6 9  
3  1  K 7  
- 1  3 3  + 0 . 9 8  
6  2  8 5  
- 0  3 5  
-- -- " - -
I  I  3  2 0  - 1  5 6  4  0 ,  0 6  - 0 . 0 1  
- 0 . 2 1  + 0 . 7 6  
2  I  7 2  - 1  6 8  
- 0 . 0 7  
- 0 . 2 7  + 0 . 7 0  
3  1  6 5  - 1  5 5  
- 0 . 2 0  +  0 . 7 7  
5  I  6 5  
- I  7 5  +  0 . 9 7  
6  2  6 2  - 0  7 8  
1  I  5 1  3  2 0  - 1  6 9  
--
I  2  0 5  3  2 0  - V  1 5  - 0 . 1 5  .. 
- 0 . 5 0  
- 0 . 3 8  .. +  1 . 6 9  + 3 . 9 8  +  0 . 7 5  
9 0  
- 1  3 0  
-- - 0 . 3 5  - 0 . 2 3  +  1 . 6 6  + 4 . 1 3  + 0 . 9 0  
•  0 . 1 2  +  1 . 9 9  + 6 . 6 8  +  1 . 2 5  
5  1  6 7  - 1  5 3  
-- -- +  1 . 8 7  + 4 . 3 6  + 1 . 1 3  
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Chart 9. (Continued) 
T  N  C o r r e c t e d  T r e a t m e n t  d i f f e r e n c e »  T  -  T  ( J  >  I )  
0  T  T  1  1  m o o n  m i - o n  1  
v n l a e  v . l u e  ( T ,  -
^ 3  ^ 5  ^ 7  ^ 8  " 9  ^ 1 0  
6  3  5 6  < 0 . 3 6  _ _  * 2 . 4 9  - 0 . 7 4  
9  f ,  0 3  •  2 . 8 3  - 3 . 2 3  
1 0  2 . H O  - 0 . 6 0  
--
3 .  T P N  
I  I  5 2 3 . 8  5 2 5 . 8  n . o  - 2 0 6  7  - 1 9 7  7  - 3 1 6 . 3  - 1 2 6 . 8  - 3 1 0  . 2  
2  3 1 7  I  - 2 ( W . 7  . 1 1  0  - 1 0 7 . 6  ^ 1 , 9  - 1 0 2  5  
3  3 2 8  1  - 1 9 7 . 7  - 1 1 8 . 6  * 7 0 , 9  - U 2  5  
U  2 0 9 . 5  - 3 l b . 3  * 1 8 9 , 5  .  6  1  
5  3 9 "  0  - 1 2 6 . 8  - 1 8 3  6  --
6  2  1 3  6  - 3 1 0 . 2  
-- --
-- --
2  1  6 3 2  0  5 2  5 . 8  - 9 3 . 8  - 2 3 1  5  - 2 0 0  2  - 1 8 3 . 5  .. • 1 9 5  3  .. .. 
2  2 0 0 .  5  - 3 2 3 . 3  -- . 3 1  3  . 6 8 . 0  •  3 6  2  
3  2 3 1  8  - 2 9 6 , 0  4 1 6 . 7  * 4  9  
u  2 A B  5  - 2  7 7 . 3  - 1 1  8  
7  2  3 6  7  - 2 8 9 . I  
-- -- -- --
3  I  1 7 1 ,  8  5 2  5  . 8  - 3 6 9 . 0  •  1 6  0  4 1 3 3 . 9  * 7 7 . 7  .. 
2  1 9 2  8  - 3 3 3 . 0  - - -- * 1 1 7 . 9  . 6 1 . 7  
U  3 1 0  7  - 2  1 3 . 1  - 5 6 . 2  --
5  2  3 6  5  - 2 7 1 . 3  
--
--
--
-- -- --
4  I  7 f . l  7  5 2  5  . 8  . 2  3 6 . 9  - 2 9 5  I  - 2 1 1  - 5 3 1  0  
2  l . u ' ,  6  . ' 0 . 2  • - . 3 6  9  - 2 3 5  9  - - - - - -
3  3 0 2  3  - 2 3 . 2  - 2  7 2  8  
2 2 9  7  - 2  9 6 .  1  " 
--
-- -- --
I  ' • 3 7  7  5 2  5  . 8  . 1 1 1 . 9  . 1 7 8  6  . 6 7  9  - 2 1 0 . 1  - 3 2  I  2  .. 
: b  1 ' - 3  . 2 9 0 . 3  - 1 1 0  7  - 3 8 8 . 7  - 6 9 9  8  
3  7 1 ) 3  l >  . 1 7 9 . 8  - - - 2 7 8 . 0  - 3 8 9  I  
3  6 2  7  - 9 8 . 2  * 1 1 1  1  
h  3 1 S  5  - 2 0 9 . 3  
-- -- -- --
f >  1  629 5  5 2  3 . 0  . 1 0 3 . 7  
--
-- --
7  1  7 6 5  8  5 2 5 . 0  . 2 1 0 . 0  .60 0  . 2 6 0 .  I  . 2 0 , 2  -176.I - 3 0 8 . 3  - 5 8 3 . 3  
2  7 7 3  6  . J 3 0 . 0  • • . 2 0 0 .  I  - 1 9 . 8  - 2 1 6 .  1  - 3 6 8 . 2  - 6 2 3 . 3  
U  9 7 3  9  . 6 3 0 .  I  - 2 1 9 . 8  -616.2 * 5 6 8 . 3  - 8 2 3 . 4  
5  7  3 f ,  0  •  2 3 0 . 2  -- • 1 9 6 . 3  - 3 2 8 . 6  - 5 0 3 . 5  ti 3  3 0 .  7  • 3 3 . 9  • 1 3 2 . 1  - 4 0 7 . 2  
9  6 2  7  - 9 H . 2  
- 2 7 5 . 1  
1 0  1 3 2  3  - 3 7 3 . 3  
--
6 .  TPNH 
I 1  3 7 3  3  3 7 3 . 3  0 . 0  - 7 2  I - 9 7  7  - 9 0 . 5  - 6 . 2  - 1 2 5  6  
2  3 0 1  2  - 7 2 .  1  - 2 5  6  - 1 8 . 6  . 6 5 . 9  - 5 3  3  
3  2  7 3  6  - 9 7 . 7  • 7 . 2  . 9 1 . 5  - 2 7  7  
l 4  2d2 H  -'JO. 3 . 8 6 . 3  - 3 6  9  
b  3 ' W  I  - 6 . 2  
- 1 1 9  2 
(, 2 6 7  9  - 1 2  3 . 6  
- - " -- • - --
2  1  133 3 3 7 3 . 3  - 2 J ? . r t  •  3 7  0  . 1 0 6  1  * 7 0 . 6  * 2 6 1 .  I 
2  1 9 2  3 - I M O . 8  • • . 6 7  1  •  3 3 . 6  * 2 2 6 ,  I 
3  2  3 9  -in.7 
- 3 3 . 5  * 1 5 7 .  0  
6  2 2 f )  1  - 1 6  7 . 2  * 1 9 0 .  5  
7  6  1 1 .  G • 6 3 . 3  
3  I  6 7  7  3  7 3 . 3  - 3 2 3 . 6  . 3 1  3  * 1 3 5 . 6  * 1 6 5 . 7  
2  7 9  0  • 2 9 6 .  3  .  * 1 0 6 . 3  * 1 1 6 . 6  
6  1 H 3  3  - 1 9 0 . 0  * 1 0 . 1  
5  1 9 3  6  - 1  7 9 . 9  
- - -- -- -- -- --
U  I  2 3 ' ,  7  3 7 3 . 3  - 1 3 6 , 6  . 2 1 6  9  - . 1 2 0  1  * 5 9  6  _ _  
2  6 3 1  6  <  7 8 . 3  - 9 6  8  - 1 5 3  3  
3  3  3<) 8  - 1 6 , 5  
- 6 0  5  
(> 2 9 6  3  - 7 7 . 0  
-- -- --
--
5  I  2 2 3  2  3 7 3 . 3  - 1 5 0 . 1  . 1 5 2  3  - 3 2  7  - 3 5 . 1  +  1 6 0  8  .. 
3 7 5  5  • 2 . 2  - 1 8 5  0  - 1 8 7 . 6  - 1 1 .  5  
3  1 9 0  5  - 1 8 2 . 8  -2.6 * 1 7 3 .  5  
5  1 8 8  I  
- 1 8 5 . 2  * 1 7 5 .  9  
6  3 6 6  0  
- 9 . 3  
Ill 
T N Corrected Treatoent difference# T. - T (J > I) 
T T •' 1 mean mem I 
value value (T. - N) 
1  1 6 3 . 7  3 7 3 . 3  - 2 0 9 . 6  
-• -- -- -- --
--
--
1  2  7 5 . 7  3 7 3 . 3  - 9 7 . 6  - 5 6 . 1  .. +  7 % 6  +  3 4 . 6  + 1 6 6 . 5  
2  2  1 9 . 6  - 1 5 3 . 7  - - +  1 3 ' . 7  +  9 0 . 4  + 2 2 2 . 6  
4  3 5 1 . 3  - 2 2 . 0  - 4 1 . 3  + 9 0 . 9  
5  3 1 0 . 0  - 6 3 . 3  + 1 3 2 . 2  
8  4 4 2 . 2  , 6 8 . 9  
9  5 1 7 . 4  + 1 4 4 . 1  
1 0  3 2 5 . 7  - 4 7 . 6  
5 .  D P N  
I  0 . 0  0 . 0  0 . 0  + 2 1 5 . 2  + 2 9 0 . 2  +  9 1 . 0  +  1 4 5 . 8  + 3 0 7 . 5  
2  2 1 5 . 2  + 2 1 5 . 2  +  7 5 . 0  - 1 2 4 . 2  - 6 9 . 4  + 9 2 . 3  
3  2 9 0 . 2  + 2 9 0 . 2  - 1 9 9 . 2  - 1 4 4 , 4  +  1 7 . 3  
4  9 1 . 0  •  9 1 . 0  +  5 4 . 8  + 2 1 6 . 5  
5  1 4 5 . 8  + 1 4 5 . 8  + 1 6 1 . 7  
6  3 0 7 . 5  + 3 0 7 . 5  
I  7 0 . 7  0 . 0  +  7 0 . 7  - 5 5 . 1  - 5 0 . 9  - 7 0 . 7  - 5 4 . 8  
2  1 5 . 6  +  1 5 . 6  + 4 . 2  - 1 5 . 6  + 0 . 3  
3  1 9 . f i  +  1 9 . 8  - 1 9 . 8  - 3 . 7  
4  0 . 0  0 . 0  +  1 5 . 9  
7  1 5 . 9  +  1 5 . 9  
-- " 
1  6 . 5  0 . 0  « 6 . 5  + 8 . 4  - 6 . 5  +  1 5 . 1  _ _  
2  1 4 . 9  +  1 4 . 9  - 1 4 . 9  +  6 . 7  
4  0 . 0  0 . 0  + 2 1 . 6  
5  2 1 . 6  +  2 1 . 6  
--
-- - -
1  1 5 . 7  0 . 0  , 1 5 . 7  - 1 5 . 7  +  1 3 . 9  +  1 3 . 8  
2  0 . 0  0 . 0  +  2 9 . 6  + 2 9 . 5  
3  2 9 . h  +  2 9 . 6  
- 0 . 1  
6  2 9 . 5  « 2 9 . 5  
--
I  1 9 . 5  0 . 0  4  1 9 . 5  +  1 6 . 6  +  1 0 . 0  +  1 2 . 2  +  1 2 . 1  
2  3 6 .  I  +  3 0 . 1  
- 6 . 6  - 4 . 4  
- ^ . 5  
3  2 9 . 5  . 2 9 . 5  - - + 2 . 2  + 2 . 1  
5  3 1 . 7  . 3 1 . 7  
- 0 . 1  
6  3 1 . 6  •  3 1 . 6  
--
I  1 5 . 1  0 . 0  •  1 5 . 1  
-- -- .. 
I  0 . 0  0 . 0  0 . 0  0 , 0  .. + 2 8 . 9  +  3 9 . 9  + 2 5 . 4  
2  0 . 0  0 . 0  
-- +  2 8 . 9  +  3 9 . 9  + 2 5 . 4  
4  2 8 . 9  •  2 8 . 9  « - +  1 1 . 0  3 . 5  
5  3 9 .  9  •  3 9 . 9  
- 1 4 . 5  
8  2 5 . 4  •  2 5 . 4  
9  1 9 . 6  •  1 9 . 6  
1 0  1 4 . 8  +  1 4 . 8  
6 .  D P M I  
1  2 4 . 6  2 4 . 6  0 . 0  
- 2 1 . 5  - 2 1 . 2  - 2 4 . 6  - 2 4 . 6  
- 2 0 . 9  
2  3 . 1  - 2 1 . 5  +  0 . 3  
- 3 . 1  - 3 . 1  +  0 . 6  
3  3 . 4  • 2 1 . 2  
- 3 . 4  - 3 . 4  +  0 . 3  
4  0 . 0  - 2 4 . 6  0 . 0  +  3 . 7  
5  0 . 0  - 2 4 . 0  + 3 . 7  
6  3 . 7  - 2 0 . 9  
" 
I  8 . 4  2 4 . 6  - I f ) . 2  •  6 . 9  +  1 . 0  +  6 . 0  .. 
- 0 . 6  
2  1 . 5  
- 2 3 . 1  +  7 . 9  +  1 2 . 9  + 6 . 3  
3  9 . 4  - 1 5 . 2  +  5  0  
- 1 . 6  4  1 4 . 4  - 1 0 . 2  
- 6 . 6  7  7 . 8  - 1 6 . 8  
1  0 . 0  2 4 . 6  - 2 4 . 6  +  6 . 7  +  1 1 . 3  + 4 9 . 6  
2  6 . 7  
- 1 7 . 9  + 4 . 6  + 4 2 . 9  
4  1 1 . 3  
- 1 3 . 3  + 3 8 . 3  
5  4 9 . 6  +  2 5 . 0  
.. _ _  
I  0 . 0  2 4 . 6  - 2 4 . 6  + 2 7 . 6  +  1 2 . 7  .. + 6 .  7  
2  2 7 . 6  o.o 
-14.9 _ _  
- 2 0 . 9  
3  
6  
1 2 . 7  
6 . 7  
- 1 1 . 9  
- 1 7 . 9  
--
-- -- • 6 . 0  
- " 
• 2 4 1 . 7  
+ 2 9 7 . 8  
+166.1 
• 2 0 7 . 4  
•  7 5 . 2  
+  1 9 . 6  
+ 1 9 . 6  
- 9 . 3  
• 2 0 . 3  
- 5 . 0  
•  5 0 . 0  
+106.1 
- 2 5 , 6  
+  1 5 . 7  
• 1 1 6 . 5  
- 1 9 1 . 7  
+ 1 4 . 8  
+  1 4 . 8  
- 1 4 . 1  
•10.6 
•10.8 
- 4 . 8  
Corrected Treatment differences 1) 
0, I, T 
1 1 mean mean 
value value (T^ - Nj I, T3 T5 Tg I,,, 
5 1 5.1 24.6 -19.6 +4.2 -2.6 - - +7.9 +0.5 . 
2 9.2 -15.4 — — -1.6 — — +3.7 -3.7 . 
3 7.6 -17.0 - - +5,3 -2.1 . 
5 12.9 -11.7 -- -7.4 » m m  
6 5.4 -19.1 
-
--
6 1 1.7 24.6 -22.9 - - " - - - - -
7 I  39.7 24.6 + 15.1 -35.3 -32.7 -28.3 mm, — « -36.5 -36.8 -37.1 
2 4.4 -20.2 — — — — +2.6 +7.0 - — - - -1.2 -1.5 -1.8 
4 7.0 -17.6 - +4.4 - - -3.8 -4.1 -4.4 
5 11.4 -13.2 — - - - - - -8.2 -8.5 -8.8 
8 3.2 -21.4 — — -0.3 -0.6 
9 2.9 -21.7 •m m -0.3 
10 2.6 -22.0 
Table 7. Absolute operative effects for operative groups within treatments 
0. N Corrected Operative differences 0. - 0. (j > i) 
TO ^ J i 
i i mean mean 0. 0, 0« 0„ 0, 0, 0, 0^ 
1 1 1 _ \ i / j 4 D b / 
value value (0. - N ) 
1. RNA 
1 1.12 1.12 0.0 — +0.08 + 2 . 9 4  +0.53 +0.27 +0.17 +0.33 
2  1.20 +0.08 — — + 2 . 8 6  +0.45 +0.19 +0.09 +0.25 
3  4.06 +2.94 -2.41 -2.67 -2.77 -2.61 
4  1.65 +0.53 -0.26 -0.36 -0.20 
5  1.39 +0.27 -0.10 +0.06 
6  1.29 +0.17 +0.16 
7  1.45 +0.33 
1 3.87 1.12 +2.75 +0.91 +0.74 -2.51 -2.51 — — -2.76 
2 4.78 ' +3.66 -0.17 -3.42 -3.42 - - -3.67 
3  4.61 +3.49 -3.25 -3.25 -3.50 
4 1.36 + 0 . 2 4  0.0 - - -0.25 
5  1.36 -0.24 -0.25 
7  1.11 -0.01 
1 8.71 1.12 +7.59 +7.59 — — -7.84 -6.13 
2  15.40 +15.18 -15.43 -13.72 
4  0.87 -0.25 +1.71 
5  1.58 +1.46 
1 6.11 1.12 +4.99 +5.20 +6.54 — — — — — — - 5 . 0 6  
2  10.31 +10.19 - - -1.34 -  - -  - -10.26 
3  11.65 +11.53 - - -11.60 
7  1.05 -0.07 
Table 7. (Continued) 
0. N Corrected Operative differences 0. - 0. (j > i) 
TO ^ ^ 0 ] 
1 i mean mean 1 0 0„ 0 0, 0^ 0, 0^ 
value value (0^ - N^) 
1 6.87 1.12 +6.75 +7,75 — -7.10 — - 7 . 2 4  
3 14.62 +14.50 — — -14.85 — - 1 4 . 9 9  
5 0.77 -0.35 — — -0.15 
7 0.63 -0.49 — 
1 9.30 1 . 1 2  +9.18 — — — — — — -7.51 -7.91 
4 2.79 + 1.67 — -0.40 
5 2.39 +1.27 — 
2 15.65 1.12 + 1 5 . 5 3  
7 3.69 1.12 +2.57 — 
7 6.01 + 4 . 8 9  — 
7 2 . 7 6  1 . 1 2  +1.64 
2. DNA 
1  3.20 3.20 0 — -0.08 +0.75 -1.23 -1.54 -1.69 -1.15 
2 3.12 -0.08 +0.83 -1.15 -1.46 -1.61 -1.07 
3  3.95 +0.75 - - -1.98 -2.29 -2.44 -1.90 
4 1 . 9 7  -1.23 - - -0.31 -0.46 +0.06 
5  1.66 -1.54 - - -0.15 +0.39 
6  1.51 -1.69 — -0.54 
7 2.05 -1.15 — 
Table 7. (Continued) 
^ 1  
0. 
X 
Oi 
mean 
va lue 
%C 
mean 
va lue 
Corrected Operative differences 0. - 0. ( j  > i) 
°i 0 
( 0 .  -  N ^ )  
°2 O3 °4 S °6 O7 
2 1 6.00 3.20 +2.80 + 1.24 + 1.33 -3.95 - 4 . 2 8  -4.10 
2 7 . 2 4  +4.04 +0.09 -5.19 -5.52 — - -5.34 
3  7.33 +4.13 -5.28 -5.61 - - -5.43 
4 2.05 -1.15 -0.33 -0.15 
5  1.72 -1.48 +0.18 
7 1.90 -1.30 
3 1 7 . 8 8  3 . 2 0  +4.68 +1.52 — — -6.01 - 6 . 2 3  
2 9.40 +6.20 -7.53 - 7 . 7 5  
4 1.87 -1.33 - 0 . 2 2  
5 1.65 -1.55 
4  •  1 5.75 3 . 2 0  +2.55 +1.02 +1.42 — — — — — — -4.70 
2 6.77 +3.57 +0.40 -5.72 
3 7.17 +3.97 -6.12 
7 1.05 -2.15 - -
5  1 5,97 3.20 +2.77 — — +2.78 — — - 4 . 5 2  — — -4.30 
3  8.75 +5.55 -7.30 - - -7.08 
5 1.45 -1.75 - - +0.22 
7 1.67 -1.53 
6 1 6.66 3.20 +3.46 — — — — -3.81 -4.24 
4  2.85 -0.35 -0.43 
5  2.42 -0.78 
7 2 8 . 4 2  3.20 5.22 
Table 7. (Continued) 
0. N Corrected 
T .  0 .  ^  0 .  
1 1 mean mean i 
value value (0^ - N^) 
8 7 3.54 3.20 +0.34 
9 7 6.03 3.20 +2.83 
10 7 2.80 3.20 -0.40 
1 5 2 5 . 8  5 2 5 . 8  0 
2 432.0 -93.8 
3 1 7 6 . 8  - 3 4 9 . 0  
4 761.7 +235.9 
5 637.7 +111.9 
6 629.5 +103.7 
7 765.8 +240.0 
1 317.1 525.8 -208.7 
2 200.5 -325.3 
3 192.8 -333.0 
4 465.6 -60.2 
5 816.3 +290.5 
7  775.6 +249.8 
1 328.1 525.8 -197.7 
2 231.8 -294.0 
4 502.5 -23.3 
5 705.6 +179.8 
Operative differences 0. - 0. (i > i) 
J 1 
O l  O 2  O 3  O 4  ° 5  0 6  O 7  
3. TPN 
-93.8 -349.0 +235.9 
-255.2 +329.7 
+584.9 
+111.9 
+205.7 
+460.9 
-124.0 
+103.7 
+196.5 
+452.7 
-132.7 
-8.2 
+240.0 
+333.8 
+589.0 
+4.1 
+ 1 2 8 . 1  
+136.3 
•116.6 124.3 
-7.7 
+148.5 
+265.1 
+ 2 7 2 . 8  
+ 4 9 9 . 2  
+615.8 
+623.5 
+350.7 
+458.5 
+575.1 
+582.8 
+310.0 
-40.7 
- 9 6 . 3  +174,4 
+270.7 
+377.5 
+ 4 7 3 . 8  
+203.1 
Table 7. (Continued) 
0. Corrected 
T. 0. ^ 0. 
1 1 mean mean i 
value value (0^ - N^) 
4 1 209.5 525.8 -316.3 
2 248.5 -277.3 
3 310.7 -215.1 
7 975.9 +450.1 
5 1 399.0 525.8 -126.8 
3 254.5 -271.3 
5  4 2 7 . 6  - 9 8 . 2  
7 756.0 +230.2 
6 1 215.6 525.8 -310.2 
4 229.7 -296.1 
5 316.5 -209.3 
7 2 236.7 525.8 -289.1 
8 7 559.7 525.8 +33.9 
9 7 427.6 525.8 -98.2 
10 7 152.5 525.8 -373.3 
1 373.3 373.3 0.0 
2 155.5 -217.8 
3 47.7 -325.6 
Operative differences 0. - 0^ (j > i) 
Oi 0; O3 0^ O5 0^ O7 
+39.0 +101,2 — — -- +766.4 
— +62.2 — — — +727.4 
— — — — +665,2 
•144.5 -- +28.6 -- +357.0 
+173.1 -- +501.5 
+14.1 +100.9 
— +8 6.8 
+ 3 2 8 . 4  
4. TPNH 
-217.8 -325.6 -136.6 -150.1 -209.6 -97.6 
-107.8 +81.2 +67.7 +«.2 +120.2 
+189.0 +175.5 +116.0 +228.0 
Table 7. (Continued) 
0. N Corrected Operative differences 0. - 0. (j > i) 
TO ^ 0 ^ i i mean mean i 0^ 0„ 0„ 0, 0, 0, 0 
value value (0^ - N^) 
4 2 3 6 . 7  -136.6 - 1 3 . 5  -73.0 +39.0 
5 2 2 3 . 2  -150.1 - - -59.0 +52.5 
6 163.7 -209.6 112.0 
7 275.7 - 9 7 . 6  
1 301.2 3 7 3 . 3  - 9 7 . 6  -83.2 -196.7 +175.9 + 9 9 . 8  — — -56.1 
2  192.5 -180.8 - - -113.5 + 2 5 9 . 1  + 1 8 3 . 0  - - +27.1 
3 79.0 -294.3 +372.6 + 2 9 6 . 5  - - +140.6 
4 451,6 + 7 8 . 3  - 7 6 . 1  -232.0 
5 375.5 + 2 . 2  -155.9 
7  219.6 -153.7 
1 275.6 373.3 -97.7 - 4 3 . 8  + 2 2 6 . 9  +430.0 
2  231.8 -141.5 +170.7 + 4 7 5 . 8  
4 502.5 +129.2 +203.1 
5 705.6 +332.3 - -
1 2 8 2 . 8  373.3 -90.5 -56.7 -99.5 — — — — — — +68.5 
2 226.1 -147.2 - - -42.8 - — +125.2 
3 183.3 -190.0 +168.0 
7 351.3 -22.0 
1 367.1 373.3 -6.2 p — — — - 1 7 3 . 7  — — -179.0 — — -57.1 
3  193.4 -179.9 -5.3 - - +116.6 
5 188.1 -185.2 +121.9 
7  310.0 -63.3 
Table 7. (Continued) 
0. N„ Corrected 
T. 0. ^ 0. 
X 1 mean mean i 
value value (0^ - N^) 
6 1 247.9 373.3 -125.4 
4 296.3 -77.0 
5 364.0 -9.3 
7 2 416.6 373.3 +43.3 
8 7 442.2 373.3 +68.9 
9 7 517.4 373.3 +144.1 
10 7 325.7 373.3 -47.6 
1  0 . 0  0 . 0  0 . 0  
2 70.7 70.7 
3 6.5 6.5 
4 15.7 15.7 
5 19.5 19.5 
6 15.1 15.1 
7 0.0 0.0 
1 215.2 0.0 215.2 
2 15.6 15.6 
3 14.9 14.9 
4 0.0 0.0 
5 36.1 36.1 
7 0.0 0.0 
Operative differences 0. - 0^ (j > i) 
°2 °3 °4 °5 °7 
5. DPN 
+48.4 +116.1 
+67.7 
+70.7 +6.5 + 15.7 +19.5 +15.1 0.0 
-64.2 -55.0 -51.2 -55.6 -70.7 
+9.2 +13.0 +8.6 -6.5 
+3.8 -0.6 -15.7 
-4.4 -19.5 
-15.1 
199.6 -200.3 -215.2 -179.1 -215.2 
- -
-0.7 -15.6 +2 0.5 — — -15.6 
- -
-14.9 +21.2 — — -14.9 
— — +36.1 — — 0.0 
-36.1 
M 
vo 
Table 7. (Continued) 
0. N Corrected Operative differences 0. - 0. (j > i) 
T 0 ^ 0 ^ 
1 i mean mean i 0, 0„ 0„ 0, 0 0, 0-
value value (0^ - N^) 
3 1 290.2 0.0 2 9 0 . 2  -270.4 -260,6 -260.7 
2 19.8 19.8 — — +9.8 +9.7 
4 29.6 2 9 . 6  -0.1 
5 29.5 29.5 - -
4 1 91.0 0.0 91.0 -91.0 -91.0 — — — — — -62.1 
2 0.0 0.0 — 0,0 - , +28.9 
3 0.0 0.0 — +28.9 
7 2 8 . 9  28.9 
5 1 145.8 0.0 145.8 — -124,2 — — -114.1 -105.9 
3 21.6 21.6 — + 10.1 +18.3 
5 31.7 31.7 +8.2 
7 39.9 39.9 - -
6 1 307.5 o
 
o
 
307.5 —. — — — -278.0 - 2 7 5 . 9  
4 29.5 29.5 - - +2.1 
5 31.6 31.6 - -
7 2 15.9 0.0 15.9 
8 7 25.4 0.0 25.4 
9 7 19.6 0.0 19.6 
10 7 14.8 0.0 14.8 
Table 7. (Continued) 
0. N Corrected Operative differences 0. - 0. (j > i) 
T 0 ^ 0 ^ i i mean mean i 0, 0^ 0_ 0, 0^ 0, 0^ 
value value (0^ - N^) 
6. DPNH 
1 2 4 . 6  24.6 0.0 -16.2 - 2 4 . 6  - 2 4 . 6  -19.5 -22.9 +15.1 
2 8.4 -16.2 — -8,4 -8.4 -3.3 -6.7 +31.3 
3 0.0 -24.6 0.0 +5.1 +1.7 +39.7 
4 0.0 - 2 4 . 6  +5.1 +1.7 +39.7 
5 5.1 -19.5 -5.4 +34.6 
6 1.7 -22.9 +38.0 
7 39.7 +15.1 - -
1 3.1 24.6 -21.5 -1.6 + 3 . 6  +24.5 + 6 . 1  —  —  +1.3 
2 1.5 -23.1 — — +5.2 +2 6.1 +7.7 - - + 2 . 9  
3 6.7 -17.9 — — +2 0.9 +2.5 — — -2.3 
4 27.6 +3.0 - - -18.4 - - -23.2 
5 9.2 -15.4 -4.8 
7 4.4 -20.2 
1 3.4 24.6 -21.2 +6.0 —  —  +9.3 +4.2 
2 9.4 -15.2 — — +3.3 -1.8 
4 12.7 -11.9 -5.1 
5 7.6 -17.0 - -
1 0.0 24.6 -24.6 — +14.4 +11.3 —  —  » — w  —  +28.9 
2 14.4 -10.2 — — -3.1 +14.5 
3 11.3 -13.3 - - +17.6 
7 28.9 +4.3 
1 0.0 24.6 -24.6 —  —  —  —  +49.6 — — + 12.9 —  —  +11.4 
3 49.6 +25.0 - - -36.7 - - -38.2 
5 12.9 -11.7 -1.5 
7 11.4 -13.2 
Table 7. (Continued) 
0^ Corrected Operative differences 0^ " 0^ (j > i) 
^i "^i mean mean ^i 0^ 0 0 0, 0^ 0 0 
value value (0^ - N^) 
6 1 3.7 24.6 -20.9 — -- — +3.0 +2.0 
46.7 -17.9 -- -1.0 
5 5.7 -18.9 
7 2 7.8 24.6 -16.8 
8 7 3.2 24.6 -21.4 
9 7 2.9 24.6 -21.7 
10 7 2.6 24.6 -22.0 
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VI. DISCUSSION 
The data shown in a previous section are in agreement with those 
found in the literature, for comparable experimentation. Since the 
purpose of this dissertation is to attempt assimulation of the biochemical-
endocrinologica1 interrelationships, a discussion of natural and artificial 
mammogenesis, as was observed from the results of the involved substances, 
is necessary. 
From the present investigations, it appears that the biochemistry 
of the gland is in a dynamic, variable state owing to conception, to 
the hormonal changes during gestation and due to parturition. In addi­
tion, it appears that the most critical indications of mammary gland 
physiology are the quantitative measurements of DNA., RNÂ./DNA, DPN/DONH 
and TPNH/TPN. These indices express the extent of new cell formation 
in the gland, of proteidogenesis for the gland, of the energy capabilities 
of the gland via the electron transport system, and of the relative rate 
of lipogenesis in the gland, respectively. Thus, to simplify this dis­
cussion only these indices of glandular function will be considered. 
A. Natural Mammogenesis 
The early work of Roberts (161) suggested that mammary gland 
development occurred in two stages. The first stage, consisting primarily 
of hyperplasia and hypertrophy, occurred up to the 13th day of pregnancy, 
and the second stage, consisting of secretory modification and enlarge­
ment of the alveoli, continued through the remainder of pregnancy and 
into lactation. This process was considered to be reversed with the 
124a 
start of involution. 
In this discussion P. and L. will be defined as the ith day of 
11 •' 
pregnancy and lactation, respectively. 
1. DNA 
The criterion of DNA measurement as a quantitative indication of 
cellular development in the gland has shown the work of Roberts (161) 
is inaccurate. Using the DNA criterion, the results herein indicate 
that glandular growth occurs both during pregnancy and lactation. This 
observation is in agreement with more recent investigations (76, 77, 141). 
The present findings indicate that the most rapid increase in total cells 
formed, during pregnancy, occurs between P^Q and P^^ (P^^ - P^^). In 
this time interval approximately 50 percent of all new cells formed 
during pregnancy and 30 percent of all cells formed during pregnancy and 
lactation are produced, as shown in Table 8. The percentage values 
shown in Table 8 were obtained by subtracting the lowest DNA reading, 
i.e., that at P^, from each of the remaining DNA values and then cal­
culating all values as a percentage of the highest correct value, i.e., 
^20* 
One can also observe from Table 8, that by P^^, approximately 45 
percent of all new cells produced during these two physiological periods 
are formed. Prior to P^g, only 14 percent of the new cells are formed, 
and between the interval P^^ - P^Q there is only a 16 percent increase 
in new cells, giving a total of nearly 60 percent of all cells produced, 
both in pregnancy and lactation, are present by P2q« 
A comparable period of rapid cellular formation during lactation 
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occurs between the interval - L^. Within this time interval 70 percent 
of all new cells produced during lactation are formed, and approximately 
32 percent of all new cells formed during both physiological periods are 
present. 
If we consider the total production of new cells during both periods, 
it is observed that by , there are present 92 percent of all cells 
produced. After there appears to be a damping out of cellular pro­
duction through the remainder of lactation, with the exception of the 
interval - I'2q- This "leveling-off" is probably due to the attain­
ment of maximal mammary gland size under the "existing" normal nursing 
conditions. The final "spurt", during the interval - ^20' 
probably related to continued nursing past as suggested by Tucker 
and Reece (180) as was allowed in this investigation. 
2. RNA-DNA ratio 
Maximal proteidogenesis, as measured by the ratio of RNA per DNA, 
occurs during late pregnancy and continues throughout lactation, as 
shown in Table 17. The most rapid increase in protein synthesizing 
abilities within pregnancy occurs between - P2Q. During this 
interval there is an 11 percent increase. Prior to P^^, the greatest 
increase is approximately 6 percent that occurs between Pq - P^. This 
early increase is probably related to a general overall increase in 
proteidogenesis due to the protein requirements of conception and initial 
pregnancy. This view is suggested by the reduction in proteidogenesis 
between - P^g. 
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Table 8, Percentage of maximum value during pregnancy and lactation 
(data corrected from Chart 1) 
Percentage of maximum corrected value 
Considered 
period 
DNA RNA/DNA DPN/DPNH TPNH/TPN 
0 0 0 0 
2 . 8 0  5 . 6 9  8.55 5.71 
Np 14.23 3.25 87.81 42.95 
10 • 
Np 43.47 6.50 61.07 49.79 
^15 
Np 59.74 1 7 . 4 8  37.60 4.19 
20 
67.24 3 1 . 3 0  100 52.67 
' s  
92.40 4 8 . 3 7  33.01 6 2 . 3 0  
N. 9 3 . 9 3  7 6 . 8 3  9 4 . 0 6  80.22 
10 
91.89 90,24 23.27 100 
^15 
100 100 9.35 51.45 
2 0 
-
Protein synthesis during lactation continues at a high rate , having 
a sigmoidal functional relation through time. This relation suggests 
proteidogenesis is required to maintain adequate milk protein to 
properly nourish the young. The reduction in rate of protein synthesis, 
after is probably related to other food sources for the litter. 
However, there was continued nursing beyond which may account for 
the continued increase of both RNA and DNA; the relative increase of 
RNA twice as high as that of DNA. 
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3. DPN-DPNH ratio 
Clock and McLean (67) and McLean (118,119,120) suggested that the 
ratio of DPNH to DPN was an indication of energy requirements of the 
cell, obtained through oxidative phosphylation. Although values were 
obtained similar to those of these investigators, the reciprocal is used 
here to imply their meaning since it is felt that the concentration of 
DPN is a direct result of this oxidation having occurred. In this way, 
it is felt, any increase in this ratio value, given variations in both 
DPN and DPNH, is an indication of periods of high oxidative phosphoryla­
tion. The data presented here suggest that the mammary gland needs 
i n c r e a s e d  e n e r g y  s o u r c e s  d u r i n g  m i d  a n d  l a t e  p r e g n a n c y ,  P ^  -  P a n d  
^20 ~ ^1' during lactation, L^ - L^^. These are, as discussed above 
associated with periods prior to a most rapid increase in either the 
number of cell in the gland, during early pregnancy, and/or to maximal 
proteidogenesis, during late pregnancy and lactation. 
4. TPNH-TPN ratio 
Since this ratio as suggested by Clock and McLean (67) is indicative 
of potential synthesizing capacity of the gland, it is suggested by the 
present data that lipogenesis occurs both in pregnancy and in lactation. 
The rate of increase in regard to this ratio value is maximal during 
pregnancy between P^ - P^^, with maximal lipogenesis, as measured by 
the ratio, occurring at P^^. In lactation, we find that the maximal 
rate of increase is between P^q - L^. From L^ - L^^, lipogenesis is 
increasing at a constant rate, with a decrease after L^^. This is 
believed to be related to the start of weaning. 
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5. Biochemica1 relationships of periods 
The total generalized picture, as suggested by the above discussion, 
indicates that mammary glands of pregnancy and lactation are, seemingly 
biochemically, different. During pregnancy the gland is increasing in 
numbers of cells, has a low rate of proteidogenesis, has a high rate of 
lipogenesis and has a relatively high energy requirement. This physiological 
period of the gland is equivalent to adipose tissue undergoing fat 
storage from fatty acids (44, 69, 70, 203). One can envisage that during 
early and mid-pregnancy the primarily biochemical function of the mammary 
gland is lipogenesis related to the formation of structural adipose 
tissue. Late pregnancy is concerned with a reduction in lipogenesis and 
an increase in protein synthesis. This period is believed to be related 
to maximal tubular development in the gland. 
During lactation, the gland continues to increase in total numbers 
of cells, with a high rate of both proteidogenesis and lipogenesis and 
maintains a high energy requirement. Lactation suggests a gland with a 
major biochemical function related to the formation of proteins and fats 
for nutritional purposes in milk (28, 45). 
B. Artificial Mammogenesis 
The present data for artificial mammogenesis will be similarly 
discussed in regards to the indices of gland function. These indices 
are found as a percentage of their respective value for N in Table 
^20 
9. In this way a comparison to the natural process using the criterion 
established in the literature can be made. 
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1. Normal animals (0^) 
a. This subgroup consisting of intact, normal animals, 
receiving no hormonal treatment. The observed percentage values of 41%, 
44%, 0.0 and 43%, gives us the lower bases unit of these indices prior 
to proliferation due to gestation. 
b. T^ When this subgroup, receiving E and P, is compared to 
the above data obtained from pregnant and lactating animals, we observe 
that the gland has increased in the total number of cells from N , with 
0 
relatively high protein synthesizing capacity, having a relatively high 
energy requirement, and a low rate of lipogenesis when compared to N 
20  
These observations are suggested from the individual percentage values 
of 76% (DM), 82% (RNA/DNA), 188% (DPN/DPNII) and 57% (TPNH/TPN), as 
shown in Table 9. 
c. T^ This subgroup received E, P and T. The percentage values 
of 100%, 141%, 232% and 50%, suggest a gland that has increased cell 
numbers equal to N , with a relatively high capacity for proteido-
2 0  
genesis, a very high energy requirement, and a very low rate of lipo­
genesis. • 
d. T^ The percentage values of 73%, 136%, infinity, and 81%, 
suggest a gland increased in size from N , with relative high protein 
0 
synthesizing abilities, an extremely high energy requirement, and a 
relatively high rate of lipogenesis. This subgroup received, E, P, D 
and H. 
e. T^ This subgroup received E, P, D, H and T. The respective 
percentage values of 76%, 147%, infinity and 55% suggest an increased 
total number of cells, relatively high protein synthesizing capabilities. 
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Table 9. Indices of gland function for various operative-treatment groups 
Considered Indices of gland function 
groups compared to N 
0. - T. l20 
^ ^ DNA RNA/DNA DPN/DPNH TPNH/TPN 
°1 
°4 
°5 
°6 
T. 0.41 0.44 0.0 0.43 
0.76 0 . 8 2  1 . 8 8  0.57 
T" 1.00 1.41 2 . 3 2  0.50 
^4 
0.73 1 . 3 6  infinity 0.81 
T. 0.76 1.47 infinity 0.55 
^6 
0 . 8 4  1.79 2 . 2 5  0 . 6 9  
T. 0 . 3 9  0 . 4 9  0.23 0 . 2 2  
0 . 9 2  0 . 8 5  0 . 2 8  0.57 
T" 1 . 1 9  0 . 8 2  0 . 0 6  0.67 
0 . 8 6  1.95 0.0 0.55 
4 
1.07 2 . 3 8  0.06 1.05 
Ti 0.50 1.31 infinity 0.16 
0 . 9 3  0.81 0 . 0 6  0.24 
^4 
0.91 2 . 0 8  0 . 0  0.35 
^5 
1.11 2 . 0 9  0.01 0.46 
^1 
0 . 2 4  1.08 infinity 0.19 
Tg 0 . 2 6  0 . 8 5  0.0 0 . 5 8  
0.24 0 . 6 0  0.05 0.43 
^6 
0 . 3 6  1 . 2 4  0.12 0 . 7 7  
T. 0 . 2 1  1 . 0 8  0.10 0 . 2 2  
^2 
0 . 2 2  1.01 0.11 0 . 2 9  
T" 0 . 2 1  1.23 0.11 0.16 
T5 0.18 0 . 6 8  0.07 0 . 2 6  
^6 
0.31 1.27 0.16 0 . 6 9  
^1 
0.19 1 . 0 9  0.24 0.16 
T. 0 . 2 6  0.91 0.0 0 . 2 2  
^2 
0.24 0 . 7 4  0.0 0 . 1 6  
^4 0 . 2 0  0 . 8 7  0.11 0 . 2 2  
T5 0.21 0 . 4 9  0.09 0 . 2 4  
0.44 1.33 0.22 0.47 
0 . 7 6  1.28 0.18 0.72 
?10 0.35 1.27 0.15 1.28 
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extremely large energy requirements and a low rate of lipogenesis. 
f. Tg This subgroup received E, P, S, M and T. The percentage 
values of 84%, 179%, 225% and 69% suggest a gland similar to the normal 
gland during mid-pregnancy, such a gland is characterized by an increase 
in cell numbers, high energy requirement, having a very high protein 
producing capacity, and a rather low rate of lipogenesis. 
2. Ovarectomized animals (C^) 
a. T^ Ovarectomized animals receiving no hormonal treatment 
appeared to be similar physiologically to the normal, untreated control 
-N , except they had higher energy requirements and a much lower rate 
0 
(50 percent) of lipogenesis. 
b. T^ This subgroup was similar to 0^ - T^, but had a much 
lower energy requirement (approximately eight times lower). 
c. T^ This subgroup suggested a gland with very high prolifera­
tion, very good proteidogenetic capabilities, very low energy needs, 
but a high rate of lipogenesis. 
d. T^ This subgroup had a relatively high rate of proliferation 
and high protein synthesizing capabilities, but an absence of energy 
from the electron transport system (possibly another source of energy 
is available), and a low rate of lipogenesis. 
e. T^ This subgroup, receiving E, P, S and M, suggested a 
gland with increased total cell numbers, the highest capacity to synthesize 
proteins, extremely low energy requirements and potential equivalent 
lipogenetic abilities potentially equivalent to those of Np 
20 
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3. Adrenalectomized-ovarectomized animals (0^) 
a. This subgroup had very little proliferation, relatively 
high proteidogenetic capacities, extremely high energy requirements, but 
an extremely low rate of lipogenesis. 
b. T^ This subgroup had a high rate of cellular formation, 
relatively high protein synthesizing capacities, little or no energy 
requirements, and a low lipogenetic rate, 
c. T^ This subgroup was similar to 0^ - Tg, but had an 
extremely high rate of proteidogenesis, 
d. T^ This subgroup was relatively identical to 0^ - T^, 
except having a higher level of proliferation. 
4, Hypophysectoraized-ovarectomized animals (0^) 
a. T^ The data from this subgroup suggested that there was 
degeneration of the cells from N , but increased proteidogenetic 
0 
abilities, an extremely high energy requirement, and a low lipogenetic 
rate. 
b. T^ This subgroup indicated a degeneration of cells resulting 
in decrease in number little or no energy requirement from the electron 
transport system, a low rate of lipogenesis, but a relatively high rate 
of protein synthesis. 
c. T^ This subgroup was similar to 0^ " ^ 2' ^ lower rate 
of proteidogenesis. 
d. Tg This subgroup, likewise, suggested cellular deterioration 
or, destruction, with a relatively high protein and lipid synthesizing 
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capacity for the existing cells, but having low energy requirements. 
5. Hypophysectomized animals (0^) 
Similar to 0^, all animals in this group indicated a decrease in 
the total number of cells from N . This group, in general, suggested 
0 
low energy requirements, a low rate of lipogenesis, but high proteido-
genetic capabilities (with the exception of 0^ - T^, which had low rate 
of proteidogenesis). 
6. Adrenalectomized-hypophysectomized animals (0^) 
This group of animals, receiving no hormonal injections, was similar 
to 0^, (cellular decrease, a high rate of proteidogenesis, low energy 
requirements, and a low rate of lipogenesis). 
7. Adrenalectomized-hypophysectomized-ovarectomized animals (0^) 
This group, in general, had low energy requirements and a decrease 
in total cell numbers. The other two indices were variable with treat­
ment . 
a. T^ This subgroup had moderate protein synthesizing capa­
bilities and a low rate of lipogenesis. 
b. T^ This subgroup was identical to 0^ - T^ in regard to 
rates of proteidogenesis and lipogenesis. 
c. T^ This subgroup was also similar in regards to the other 
two indices to 0^ - T^. 
d. T^ This subgroup had a low potential for synthesizing protein, 
being equivalent to N , and had a low lipogenetic rate. 
0 
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e. Tg This subgroup had a relatively high rate for proteido-
genesis and a relatively low rate for lipogenesis. This subgroup 
received E, P, D, H, S, and T. 
f. Tg This subgroup received E, P, D, H, M, and T had a 
relatively high rate of both proteidogenesis and lipogenesis. In 
addition, this subgroup had an increase in total cell numbers over N , 
0 
but less than N 
2 0  
g. T^q This subgroup had a relatively high rate of protein 
synthesis and a very high rate of lipogenesis. This subgroup receive 
as hormonal treatment E, P, D, H, S, M, and T. 
8. Biochemica1 relationships of operative-treatment groups 
The data presented herein indicates that while visually, as shown 
in the histological preparations, there appears equivalence between 
certain of the operative-treatment groups and N , and while one or 
2 0  
more of the indices of gland function may, likewise, be similar to N , 
2 0  
there is no one experimental group equivalent to N for all indices. 
2 0  
These observations are suggested by Table 9. Thus if we use N as 
^20 
the £ priori criterion of maximal glandular growth, there is no hormonal 
preparation studied in this limited series of experiments that will 
produce a gland functioning as a normal one in very late pregnancy for 
all indices. It would appear that one or more factors are missing from 
the present experimentation to make normal glandular growth impossible. 
The work of Willmer (202), reflects this view in his work on the bio­
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chemical effects resulting from adrenalectomy and replacement hormonal 
therapy. It seems that a more thorough investigation of the synergistic 
actions of endocrine glands, their hormones and the important biochemical 
factors is necessary before a full understanding of the changes occurring 
during pregnancy and/or lactation can be obtained. 
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VII. SUMMARY 
The present experimentation was concerned with the biochemical-
endocrinological interrelationships of the mammary gland of the rat. To 
accomplish this purpose, four indications of gland function were advanced 
as a criterion. These indices were the quantitative measurements of DNA., 
RNA./DNA, DPN/DPNH, and TPNH/TPN as they express the extent of new cell 
formation in the gland, of proteidogenesis for the gland, of the energy 
capabilities of the gland via the election transport system, and of the 
relative rate of lipogenesis in the gland, respectively. 
The results given herein suggest the following: 
1. That during early and mid-pregnancy the mammary gland is acting 
similar to adipose tissue primarily for the storage of fat. 
2. That during late pregnancy the gland is actively undergoing new 
cell formation primarily related to the formation of tubular structures, 
but to some alveolar proliferation. 
3. That parturition stimulates great activity in the gland 
primarily related to the formation of proteins and fats for nutritional 
purposes, but also concerned with continued alveolar proliferation. 
4. That early and mid-lactation continue to reflect the glandular 
changes stimulated by parturition. 
5. That late lactation, as believed related to the start of weaning, 
reflects a decrease in the rate of lipogenesis and a "leveling-off" in 
the rates of proteidogenesis, as an attempt to begin involution. 
6. That the periods of pregnancy and lactation are physiologically 
and biochemically different, due to requirements of the gland during 
136 
these periods. 
7. That when normal and surgically ablated, non-pregnant rats 
with or without varying hormonal therapy are compared to normal, twenty 
day pregnant animals, N , no operative-treatment group is similar for 
2 0  
all measured indices of glandular function. 
The present experimentation suggests that more involved experimenta­
tion is necessary to understand the complete interactions of hormones on 
the physiology and biochemistry of the gland during various stages of 
growth and function. 
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X. APPENDIX 
A. Chemical Methodology 
The following preparatory, analytical, and histological methods 
were used in this exporiniencation. 
1. DNA and RNA determinations (150) 
a. Mammary gland tissue was frozen for not less than 4 days to 
remove excess water, 
b. After 4 or more days the tissue was minced and placed in 50 ml 
of CHCl^iCH^OH mixture, 2:1, for 24 hours, doing this 24 hour 
period at 20° C, the mixture was poured off and fresh mixture 
was added every 8 hours, i.e., 3 extractions to lipid. 
c. The essentially lipid free was further extracted with 50 ml of 
anhydrous ethyl-ether for 24 hours, to remove any remaining 
lipids or water leaving dehydrated-fat-free-tissue (DFFT). 
d. The DFFT was dried in an oven, preset at 50° C, until all odor 
of ether was gone. 
e. The dry DFFT was suspended in 1.ON PGA and stored at 4° C for a 
total of 18 hours to remove RNA. The supernatant was removed 
every 6 hours and the residue re-suspended. Approximately 10 
ml of the acid was used with each suspension. 
f. The final residue from (e) was suspended in 10 ml of 1.ON PGA 
and heated for 30 minutes at 85°C to extract the DNA. This 
was decanted. A second 10 ml portion of acid was added to the 
decanted residue and heated again at 85°C for 30 minutes. The 
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supernatants was added to yield 20 ml of DNA. 
g. An aliquot of the DNA extracts were read in the Spectronic 505 
at 260 raid against DNA-PCA standards and an l.ON PCA blank. 
h. An aliquot from the RNA supernatants obtained in (e) were read 
in the Spectronic 505 at 260 mn against a PCA blank and RNA-
PCA standards. 
2. Coenzyme preparations (68) 
a. Equal portions of mammary gland tissue (50-250 rag) were placed 
into 2 glass homogenizers, containing hot 5 ml of 0.IN HCl 
and 5 ml O.lNaOH, the containers were placed for 0.5 minute in 
a hot-water bath, and then homogenized for 1.5 minute. 
b. The tissue and fluid were immediately transferred into an ice 
bath after homogenization until cold. 
c. Buffer, 0.5 M tris at pH 8.7, was added to each homogenate and 
the volume adjusted to 15 ml by the addition of distilled and 
deionized water. 
d. The acid homogenate was then neutralized, cautiously, with 5 ml 
of 0.IN NaOH (containing oxidized coenzyme) and the alkaline 
homogenate was neutralized with 5 ml of O.IN HCl (containing 
reduced coenzymes). 
e. These neutralized homogenates were centrifuged at 20,000 g for 
30 minutes at 0° C and filtered to remove fat globules. These 
preparations were stored at 0° C for assay of the coenzymes. 
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DPN and TPN determinations (27,68) 
a. DPN was reduced in the presence of ethanol (0.5M ethanol in 
0.1 M tris at pHlO.1) and yeast alcohol dehydrogenase (27). 
The samples were read in the Spectronic 20 at 340 raji against 
standard DPN preparations and recommended enzyme blank. 
b. TPN was reduced in the presence of isocitric dehydrogenase 
(68), along with DPN, of sodium isocitrate (0.05M), MgCl^ (O.IM) 
and 0.1 tris at pH 7.4. These were read in the Spectronic 20 
at 340 m/i. The total TPN was determined as mentioned in the 
Results. 
DPNH and TPNH determinations (27,191) 
a. DPNH was oxidized along with TPNH in the presence of dia-
phorase (Clostridium kluyveri), tris (0.2M at pH 7.5) and 2,6-
sodium dichlorophenolindophenol (27,191). These were read in 
the Spectronic 505 against standard TPNH-DPNH preparations and 
the required enzyme blank. The total TPNH was determined as 
mentioned in the Results. 
b. DPNH was oxidized in the presence of diaphorase (pig heart), 
tris (0.2M at pH 7.5) and 2,6-sodium dichlorophenol indophenol 
(27), and were read against appropriate standards and a blank 
in the Spectronic 505. 
Histologica1 preparations (107) 
a. A section of mammary tissue was placed on a sheet of filter 
paper, spread out and allowed to dry for 2-3 minutes. 
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After approximately 3 minutes the paper and tissue were 
submerged into 10% formalin and left overnight. 
Upon removal of the paper-tissue preparations from the formalin 
it was washed in distilled water and stained with alum-carmine 
for approximately 24 hours (or until the mammary parenchyma 
was well stained). 
When properly stained the preparation was washed again in 
distilled water and dehydrated in graded ethanol (75,80,95, and 
100%) for at least one hour--with 2 one-half hour changes. 
Fat was removed in 2 changes, at least 1 hour each, of toluene. 
After toluene, the preparation is placed in 2 changes of 
dioxane to remove the toluene. 
These fixed preparations upon removal from dioxane were 
separated, cut at 50/i and embedded. 
